This Amendment No. 1 (“Amendment”)
to the Annual Report on Form 10-K/A amends the Annual Report on Form 10-K of the Company for the year ended December 31, 2021, as filed
with the Securities and Exchange Commission (“SEC”) on March 10, 2022 (the “Original Filing”), to restate our
financial statements as of December 31, 2021 (the “Restatement”), including describing the Restatement and its impact on
previously reported amounts.
The Company has re-evaluated the
Company’s application of ASC 815-40 to its accounting for the derivative liability as a result of the Subscription Agreements
(as defined below) entered into on November 4, 2021. As more fully described in Note 6 to the restated financial statements,
pursuant to the Subscription Agreements, Additional Shares (as defined below) may be issued to certain investors based on
conditions and terms set forth in the Subscription Agreements. As a result, the Subscription Agreements create a potential
obligation to issue Additional Shares and therefore, the Company should have classified this instrument to issue Additional Shares
as a derivative liability in the Original Filing. Under this accounting treatment, the Company is required to measure the fair value
of the PIPE derivative liability (as defined in the restated financial statements) on the date of issuance, and at the end of each
reporting period and recognize any change in fair value in the Company’s operating results for the current period.
The Company has also re-evaluated its going
concern assessment as of December 31, 2021. The Company has a sponsor commitment of $3,000,000, which the Company believed would alleviate
any substantial doubt about the Company’s ability to continue as a going concern that might have resulted from the need to
raise additional capital. However, the Company did not consider that it needs approval from TradeStation Group, Inc. (“TradeStation”)
to borrow any additional amounts over $500,000, and it is uncertain whether any such approval could be obtained. As a result, the Company
may not be able to utilize the sponsor commitment or obtain additional financing that it would require to continue as a going concern.
Based on the re-evaluation, management has determined that as of December 31, 2021, there is a substantial doubt about the Company’s
ability to continue as a going concern, which is disclosed in the restated financial statements in this Amendment.
In addition, this Amendment includes additional information pertaining
to the following items (i) the Amendment to the Merger Agreement dated December 17, 2021, which impacted, among other things, the formula
to convert common stock held by our public stockholders upon consummation of the proposed business combination, (ii) the Additional Shares
described in the Subscription Agreement and (iii) the Incentive Shares described in the Subscription Agreement, all of which were not
disclosed in the Original Filing.
In connection with the Restatement, the
Company’s management reassessed the effectiveness of its disclosure controls and procedures for the periods affected by the
Restatement. As a result of that reassessment, the Company’s management determined that its disclosure controls and procedures
as of December 31, 2021 were not effective due to the material weaknesses with respect to compiling information to prepare our
financial statements in accordance with U.S. GAAP. The material weaknesses are due to the previously omitted subsequent event
disclosure of an advance from Quantum Ventures, the analysis and full disclosure of the Merger Agreement, the impact of the Merger
Agreement on our going concern assessment and the impact of the Merger Agreement as it relates to the classification of
our complex accounting instruments, as well as the related determination of the fair value of the PIPE derivative liability,
accumulated deficit, net loss and related financial disclosures. For more information, see the revised Item 9A included in this
Amendment.
In addition, subsequent to the Original Filing,
we are disclosing in this Amendment that on March 14, 2022, we issued an unsecured promissory note evidencing Working Capital Loans (as
defined below), effective as of January 3, 2022, in the amount of up to $480,000 to Quantum Ventures (as defined below), as further described
herein, which was not disclosed in the Original Filing.
The following items have been amended to reflect
the Restatement, going concern assessment, and the promissory note, as well as updates to certain risk factors related to the TradeStation
Business Combination (as defined herein):
PART
I
ITEM
1. BUSINESS
General
We
are a blank check company incorporated as a Delaware corporation on October 1, 2020, for the purpose of entering into a merger,
share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one
or more businesses or entities, which we refer to throughout this Annual Report as our “initial business combination.”
While we may pursue an initial business combination in any region or sector, we have initially focused our efforts on identifying
high-growth financial services and FinTech businesses with an estimated enterprise value up to $1.0 billion as targets for our
initial business combination.
On
October 23, 2020, Quantum Ventures, our sponsor, purchased 4,312,500 founder shares from us for $25,000, or $0.006 per share. In January
2021, Quantum Ventures sold 813,500 founder shares to Chardan Quantum and 35,000 founder shares to each of our directors, in each case
at the original price per share, resulting in Quantum Ventures holding a balance of 3,254,000 founder shares. On February 4, 2021, we
effected a stock dividend of 718,750 shares with respect to our common stock, resulting in our initial stockholders holding an aggregate
of 5,031,250 founder shares.
The
registration statements on Form S-1 (File Nos. 333-252226 and 333-252761) for our initial public offering were declared effective
by the Securities and Exchange Commission (the “SEC”) on February 4, 2021. On February 9, 2021, we consummated our initial
public offering of 17,500,000 units at $10.00 per unit, generating gross proceeds of $175,000,000. Each unit consists of one share of
common stock and one redeemable warrant, with each warrant entitling the holder thereof to purchase one half-share of common stock at
a price of $11.50 per full share. On February 12, 2021, the underwriters exercised their over-allotment option in full, resulting in
our issuance of an additional 2,625,000 units at a public offering price of $10.00 per unit. After giving effect to the exercise and
close of the option, an aggregate of 20,125,000 units have been issued in the initial public offering, with aggregate gross proceeds
of $201,250,000.
Simultaneously
with the consummation of our initial public offering, we consummated the private placement of 4,450,000 private warrants to Quantum Ventures
and 1,112,500 private warrants to Chardan Quantum, in each case at a price of $1.00 per private warrant, generating gross proceeds of
$5,562,500. In connection with the full exercise of the underwriters’ over-allotment option, Quantum Ventures purchased an additional
472,500 private warrants and Chardan Quantum purchased an additional 118,125 private warrants, in each case, at a price of $1.00 per
private warrant, generating additional gross proceeds of $590,625.
A
total of $201,250,000 from the net proceeds of the sale of the units in our initial public offering and the sale of the private placements,
including as a result of the full exercise of the underwriters’ over-allotment option, was placed in a trust account established
for the benefit of our public shareholders (the “trust account”), with Continental Stock Transfer & Trust Company
acting as trustee, and has been invested only in U.S. government treasury bills, notes and bonds with a maturity of 185 days or less
or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended (the “Investment
Company Act”) and which invest solely in U.S. Treasuries. Except for all interest income that may be released to us to pay our
tax obligations and for dissolution expenses up to $100,000, as applicable, none of the funds held in the trust account will be released
from the trust account until the earlier of: (i) the consummation of our initial business combination by August 9, 2022 (or February
9, 2023, as applicable) if we have executed a letter of intent, agreement in principle or definitive agreement for an initial business
combination by August 9, 2022, and (ii) a redemption to public stockholders prior to any voluntary winding-up in the event we do not
consummate our initial business combination within the applicable period.
We incurred $5,017,526 in transaction costs, including $4,528,125 of underwriting fees and $489,401 of other offering costs. In addition,
a marketing fee of $7,043,750 is payable to Chardan pursuant to a Business Combination Marketing Agreement.
Our
units began trading on February 5, 2021 on the New York Stock Exchange (the “NYSE”) under the symbol “QFTA.U.”
Commencing on March 10, 2021, the shares of common stock and warrants comprising the units began separate trading on the NYSE under the
symbols “QFTA” and “QFTA WS,” respectively. Those units not separated continue to trade on the NYSE under the
symbol “QFTA.U.”
Significant
Events and Transactions
We entered into an Agreement
and Plan of Merger (the “Original Agreement” and, as amended by the Amendment (defined below), the “Merger Agreement”)
with TradeStation on November 4, 2021. Pursuant to the Merger Agreement, and assuming the satisfaction or waiver of various closing conditions,
including approval of the Merger Agreement by our stockholders, TSG Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary
of TradeStation, will merge with and into the Company (the “Merger”), with the Company continuing as the surviving corporation
and a wholly owned subsidiary of TradeStation (the “TradeStation Business Combination”).
On December 17, 2021, we entered into a First Amendment to the Original
Agreement (the “Amendment”) with TradeStation, which caps the exchange ratio for which public shares will be exchanged for
shares of TradeStation common stock in the Merger at 1.3727 shares, which is equivalent to the exchange ratio in scenarios where 90% of
the public shares are redeemed. In connection with the closing of the TradeStation Business Combination (the “Closing”), each
public share that is outstanding and has not been redeemed will be converted into a number of shares of TradeStation common stock equal
to the lower of (A) 1.3727 and (B) (1) the sum of (x) the number of public shares outstanding for which holders have not elected redemption
as of immediately prior to the Closing plus (y) 750,000 divided by (2) the number of public shares outstanding for which holders have
not elected redemption immediately prior to the Closing. Prior to the Amendment, 750,000 additional shares would have been distributable
pro rata to the public stockholders that elected not to redeem.
Additionally, the Company
and TradeStation entered into subscription agreements (collectively, the “Subscription Agreements”), each dated as of November
4, 2021, with certain investors (collectively, the “PIPE Investors”) pursuant to which, among other things, the Company agreed
to issue and sell, in private placements to close immediately prior to the Closing, an aggregate of 12,500,000 shares of our common stock
for $10.00 per share (the “Company PIPE Shares”), including 5,000,000 shares to Monex Group, Inc. (“Monex”), which
is currently the sole stockholder of TradeStation. The PIPE Investment will be consummated substantially concurrently with the Closing,
subject to the terms and conditions contemplated by the Subscription Agreements. The Company PIPE Shares will be converted in the Merger
into an equal number of shares of TradeStation common stock.
Subject
to limitations described below, in the event that the Adjustment Period VWAP (as defined below) is less than $10.00 per share of
TradeStation common stock (as adjusted for any stock split, reverse stock split or similar adjustment following the Closing), each
PIPE Investor, other than Monex, shall be entitled to receive from TradeStation a number of additional shares of TradeStation common
stock equal to the product of (x) the number of Company PIPE Shares, excluding any Incentive Shares (as defined below) issued to
such PIPE Investor at the Closing that such PIPE Investor holds through the Measurement Date (as defined below), multiplied by (y) a
fraction, (A) the numerator of which is $10.00 (as adjusted for any stock split, reverse stock split or similar adjustment following
the Closing) minus the Adjustment Period VWAP, and (B) the denominator of which is the Adjustment Period VWAP (such additional
shares, the “Additional Shares”). If (i) at any time from the Closing through the Measurement Date, a PIPE Investor is
not the record and beneficial owner of or otherwise transfers the TradeStation common stock into which the Company PIPE Shares are
converted at the Closing , other than ordinary course of business pledges as part of prime brokerage or other similar financing
arrangements permitted under the Subscription Agreements; or (ii) at any time from the Closing through the Measurement Date, the
PIPE Investor or any person or entity acting on its behalf, at its direction or pursuant to any understanding with the PIPE Investor
directly or indirectly engages in any transaction in breach of the prohibition in the Subscription Agreements on “short
sales,” the PIPE Investor will automatically and irrevocably forfeit any right to or interest in any Additional Shares.
Monex
will participate in the PIPE Investment and has agreed to purchase 5,000,000 Company PIPE Shares pursuant to a Subscription Agreement
on substantially the same terms and conditions as the other PIPE Investors; provided that it will not be entitled to
receive any Additional Shares. The Company will issue to any PIPE Investor or group of PIPE investors, other than Monex, whose aggregate
subscription amount for Company PIPE Shares is equal to or greater than $5 million, an additional number of Company PIPE Shares (the
“Incentive Shares”), equal to 10.0% of such aggregate subscribed-for Committed Shares for no additional consideration (which
will result in the issuance of an aggregate of 750,000 additional Incentive Shares). No PIPE Investor will be entitled to receive any
Additional Shares in respect of the Incentive Shares.
For purposes of the Subscription Agreements: (i) the “Adjustment
Period VWAP” means the higher of (x) the lower of (A) the average of the VWAP of a share of TradeStation common stock, determined
for each of the successive 60 Trading Days of the Adjustment Period (as defined below) and (B) the average of the VWAP of a share of TradeStation
common stock determined for each of the successive 10 trading days ending on and including the last day of the Adjustment Period and (y)
$6.50; (ii) the “Adjustment Period” means the 60 trading day period beginning on and including the date a resale registration
statement for the PIPE shares is declared effective; and (iii) the “Measurement Date” means the last day of the Adjustment
Period.
Additionally,
we entered into a Sponsor Support Agreement (the “Sponsor Support Agreement”) with TradeStation, Monex and the initial stockholders,
pursuant to which, among other things, the initial stockholders agreed to vote any of the shares of common stock held by them
in favor of the TradeStation Business Combination and not to redeem any such shares at the special meeting of stockholders to be held
in connection with the TradeStation Business Combination. In addition, the insiders agreed not to transfer (i) their TradeStation common
stock following the Closing, subject to certain exceptions, until the earlier of (A) (1) in the case of co-sponsors, 12 months from Closing
and (2) in the case of the company’s directors and officers, 6 months from Closing and (B) subsequent to the Closing, the date
on which the last reported sale price of TradeStation common stock exceeds $12.50 per share for 20 out of any 30 consecutive trading
days and (ii) their TradeStation warrants following the Closing, subject to certain exceptions, until the later of (A) 30 days from
Closing and (B) February 4, 2022.
Refer
to Note 6 to our financial statements for further details on the TradeStation Business Combination, the Merger Agreement, the
Subscription Agreements and the Sponsor Support Agreement.
Business
Strategy
We
intend to identify high growth FinTech acquisition targets by leveraging the expertise of our management team. Our management team maintains
robust deal sourcing channels and industry-leading relationships across the FinTech landscape.
NYSE
rules require that we must complete one or more business combinations having an aggregate fair market value of at least 80% of the value
of the assets held in the trust account (excluding the deferred underwriting commissions and taxes payable on the interest earned on
the trust account) at the time of our signing a definitive agreement in connection with our initial business combination. Our board of
directors will make the determination as to the fair market value of our initial business combination. If our board of directors is not
able to independently determine the fair market value of our initial business combination, we will obtain an opinion from an independent
investment banking firm or another independent entity that commonly renders valuation opinions with respect to the satisfaction of such
criteria. While we consider it unlikely that our board of directors will not be able to make an independent determination of the fair
market value of our initial business combination, it may be unable to do so if it is less familiar or experienced with the business of
a particular target or if there is a significant amount of uncertainty as to the value of a target’s assets or prospects.
We
anticipate structuring our initial business combination either (i) in such a way so that the post-transaction company in which
our public stockholders own shares will own or acquire 100% of the equity interests or assets of the target business or businesses, or
(ii) in such a way so that the post-transaction company owns or acquires less than 100% of such interests or assets of the
target business in order to meet certain objectives of the target management team or stockholders, or for other reasons. However, we
will only complete an initial business combination if the post-transaction company owns or acquires 50% or more of the outstanding
voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register
as an investment company under the Investment Company Act of 1940, as amended, (the “Investment Company Act”). Even if the
post-transaction company owns or acquires 50% or more of the voting securities of the target, our stockholders prior to the initial
business combination may collectively own a minority interest in the post-transaction company, depending on valuations ascribed
to the target and us in the initial business combination. For example, we could pursue a transaction in which we issue a substantial
number of new shares in exchange for all of the outstanding capital stock of a target. In this case, we would acquire a 100% controlling
interest in the target. However, as a result of the issuance of a substantial number of new shares, our stockholders immediately prior
to our initial business combination could own less than a majority of our outstanding shares subsequent to our initial business combination.
If less than 100% of the equity interests or assets of a target business or businesses are owned or acquired by the post-transaction company,
the portion of such business or businesses that is owned or acquired is what will be taken into account for purposes of NYSE’s
80% fair market value test. If the initial business combination involves more than one target business, the 80% fair market value test
will be based on the aggregate value of all of the transactions and we will treat the target businesses together as the initial business
combination for purposes of a tender offer or for seeking stockholder approval, as applicable.
In
addition to any potential business candidates we may identify on our own, we anticipate that other target business candidates will be
brought to our attention from various unaffiliated sources, including investment market participants, private equity funds and large
business enterprises seeking to divest non-core assets or divisions.
In
evaluating a prospective target business, we expect to conduct an extensive due diligence review which will encompass, as applicable
and among other things, meetings with incumbent management and employees, document reviews, interviews of customers and suppliers, inspection
of facilities, and a review of financial and other information about the target and its industry.
We
are not prohibited from pursuing an initial business combination with a company that is affiliated with our co-sponsors, officers or
directors, nor are we prohibited from partnering, submitting joint bids, or entering into any similar transaction with our co-sponsors,
or an affiliate of our co-sponsors, in the pursuit of an initial business combination. If we seek to complete an initial business combination
with such a company or we partner with our co-sponsors, or any of their affiliates in our pursuit of an initial business combination,
we, or a committee of independent directors, will obtain an opinion from an independent investment banking firm that is a member of FINRA
or an independent accounting firm, and reasonably acceptable to Chardan, with respect to fair market value that the business combination
is fair to our stockholders from a financial point of view.
If
any of our officers or directors becomes aware of a business combination opportunity that falls within the line of business of any entity
to which he or she has pre-existing fiduciary or contractual obligations, he or she may be required to present such business combination
opportunity to such entity prior to presenting such business combination opportunity to us. Certain of our directors currently have relevant
fiduciary duties or contractual obligations that may take priority over their duties to us.
Acquisition
Criteria
Consistent
with our business strategy, we have identified the following general criteria and guidelines that we believe are important in evaluating
a prospective business target. We utilize these criteria and guidelines in evaluating acquisition opportunities, but these are not intended
to be exhaustive and management will independently review the merits of an initial business combination. No individual criterion will
entirely determine a decision to pursue an opportunity, but we intend to acquire companies that we believe:
|
● |
Are high-growth FinTech
businesses which operate within large and expanding markets with significant whitespace opportunity; |
|
● |
Are of meaningful scale
and whose products and/or services are materially differentiated from competitors creating meaningful barriers to entry for new competitors; |
|
● |
Operate a superior unit
economic model which either currently or over time are expected to generate profitable, stable and predictable cash flow generation
for the business; |
|
● |
Are at a capital inflection
point where significant risk-adjusted shareholder value can be generated through a business combination and resulting access
to the broader equity capital markets to drive growth; |
|
● |
Possess a best-in-class management
team with a track record of success in driving growth and profitability within FinTech market; |
|
● |
Maintain superior and scalable
risk management, underwriting, data analytics, monitoring and reporting processes; and |
|
● |
Promote financial inclusion
and provide significant value to the underlying end consumer or enterprise through a lowering of transaction costs or through providing
access to high-quality scalable financial services. |
These
criteria and guidelines are not intended to be exhaustive. Any evaluation relating to the merits of a particular initial business combination
may be based, to the extent relevant, on these general guidelines as well as other considerations, factors and criteria that our management
may deem relevant. In the event that we decide to enter into our initial business combination with a target business that does not meet
the above criteria and guidelines, we will disclose that the target business does not meet the above criteria in our shareholder communications
related to our initial business combination, which would be in the form of proxy solicitation materials or tender offer documents that
we would file with the SEC.
Competition
In
identifying, evaluating and selecting a target business for our initial business combination, we have encountered intense competition
from other entities having a business objective similar to ours, including other blank check companies, private equity groups and leveraged
buyout funds, and operating businesses seeking strategic acquisitions. Many of these entities are well established and have significant
experience identifying and effecting business combinations directly or through affiliates. Moreover, many of these competitors possess
greater financial, technical, human and other resources than us. Our ability to acquire larger target businesses will be limited by our
available financial resources. This inherent limitation gives others an advantage in pursuing the acquisition of a target business. Furthermore,
the requirement that we acquire a target business or businesses having a fair market value equal to at least 80% of the value of the
trust account (excluding any deferred underwriters’ fees and taxes payable on the income earned on the trust account) at the time
of the agreement to enter into the business combination, our obligation to pay cash in connection with our public stockholders who exercise
their redemption rights and the number of our outstanding warrants and the future dilution they potentially represent may not be viewed
favorably by certain target businesses. Any of these factors may place us at a competitive disadvantage in successfully negotiating our
initial business combination.
Employees
We
currently have three executive officers. These individuals are not obligated to devote any specific number of hours to our matters but
they have and will continue to devote as much of their time as they deem necessary to our affairs until we have completed our initial
business combination. The amount of time they devote in any time period will vary based on whether a target business has been selected
for our initial business combination and the stage of the business combination process we are in. We do not intend to have any full time
employees prior to the consummation of our initial business combination.
Our
Website
Our
corporate website address is www.qftacorp.com. The information contained on, or accessible through our corporate website or any other
website that we may maintain is not incorporated by reference into this Annual Report.
Periodic
Reporting and Financial Information
We
have registered our units, shares of common stock and warrants under the Exchange Act and have reporting obligations, including the requirement
that we file annual, quarterly and current reports with the SEC. In accordance with the requirements of the Exchange Act, our annual
report will contain financial statements audited and reported on by our independent registered public accountants.
We
will provide stockholders with audited financial statements of the prospective target business as part of any proxy solicitation sent
to stockholders to assist them in assessing the target business. In all likelihood, the financial information included in the proxy solicitation
materials will need to be prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP,
or international financial reporting standards, or IFRS as issued by the International Accounting Standards Board or the IASB, depending
on the circumstances, and the historical financial statements may be required to be audited in accordance with the standards of the Public
Company Accounting Oversight Board (United States), or PCAOB. The financial statements may also be required to be prepared in accordance
with U.S. GAAP for the Form 8-K announcing the closing of an initial business combination, which would need to be filed within four business
days thereafter. We cannot assure you that any particular target business identified by us as a potential acquisition candidate will
have the necessary financial information. To the extent that this requirement cannot be met, we may not be able to acquire the proposed
target business.
We
are required to comply with the internal control requirements of the Sarbanes-Oxley Act beginning for the fiscal year ending December
31, 2021. A target company may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding adequacy of their internal
controls. The development of the internal controls of any such entity to achieve compliance with the Sarbanes-Oxley Act may increase
the time and costs necessary to complete any such acquisition.
We
are an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such,
we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies
that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic
reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and
stockholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive
as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.
In
addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended
transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other
words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise
apply to private companies. We intend to take advantage of the benefits of this extended transition period.
We
will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of
the completion of our initial public offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which
we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds
$700 million as of the last business day of our most recently completed second fiscal quarter, and (2) the date on which we have issued
more than $1.0 billion in non-convertible debt securities during the prior three-year period. References herein to “emerging growth
company” shall have the meaning associated with it in the JOBS Act.
Additionally,
we are a “smaller reporting company” as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take
advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements.
We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our common stock held
by non-affiliates exceeds $250 million as of the end of that year’s second fiscal quarter, or (2) our annual revenues exceeded
$100 million during such completed fiscal year and the market value of our common stock held by non-affiliates exceeds $700 million as
of the end of that year’s second fiscal quarter.
ITEM
1A. RISK FACTORS
Summary
of Risk Factors
An
investment in our securities involves a high degree of risk. The occurrence of one or more of the events or circumstances described in
this section, alone or in combination with other events or circumstances, may materially adversely affect our business, financial condition
and operating results. In that event, the trading price of our securities could decline, and you could lose all or part of your investment.
Such risks include, but are not limited to:
|
● |
We are a blank check company
in the early stage with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our
business objective. |
|
● |
Our search for a business
combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected
by the recent coronavirus (COVID-19) outbreak and the status of debt and equity markets. |
|
● |
Our public stockholders
may not be afforded an opportunity to vote on our proposed business combination, which means we may consummate our initial business
combination even though a majority of our stockholders do not support such a combination. |
|
● |
Your only opportunity to
affect the investment decision regarding a potential business combination may be limited to the exercise of your right to redeem
your shares from us for cash. |
|
● |
Management’s flexibility
in identifying and selecting a prospective acquisition candidate, along with our management’s financial interest in consummating
our initial business combination, may lead management to enter into an acquisition agreement that is not in the best interest of
our stockholders. |
|
● |
Certain of our officers
and directors are affiliated with entities engaged in business activities similar to those intended to be conducted by us and, accordingly,
may have conflicts of interest in allocating their time and determining to which entity a particular business opportunity should
be presented. |
|
● |
The ability of our public
stockholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets,
which may make it difficult for us to enter into a business combination with a target. |
|
● |
If we seek stockholder
approval of our business combination, our co-sponsors, directors, officers and their affiliates may elect to purchase shares from
stockholders, in which case they may influence a vote in favor of a proposed business combination that you do not support. |
|
● |
The ability of our public
stockholders to exercise their redemption rights may not allow us to effectuate the most desirable business combination or optimize
our capital structure. |
|
● |
The requirement that we
complete our initial business combination by August 9, 2022 (or February 9, 2023, as applicable) may give potential target businesses
leverage over us in negotiating our initial business combination. |
|
● |
Our independent registered public accounting firm’s report contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a “going concern.” |
|
● |
If we seek stockholder
approval of our business combination, our co-sponsors, directors, officers and their affiliates may elect to purchase shares from
stockholders, in which case they may influence a vote in favor of a proposed business combination that you do not support. |
|
● |
You will not have any rights
or interests in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment,
you may be forced to sell your public shares, potentially at a loss. |
|
● |
Our securities may not
continue to be listed on the NYSE in the future, which could limit investors’ ability to make transactions in our securities
and subject us to additional trading restrictions. |
|
● |
You are not entitled to
protections normally afforded to investors of many other blank check companies. |
|
● |
If the net proceeds of
the initial public offering not being held in the trust account are insufficient to allow us to operate until August 9, 2022 (or
February 9, 2023, as applicable) it could limit the amount available to fund our search for a target business or businesses and our
ability to complete our initial business combination, and we will depend on loans from Quantum Ventures, its affiliates or members
of our management team to fund our search and to complete our initial business combination. |
|
● |
If we are unable to complete
our initial business combination, our public stockholders may be forced to wait until August 9, 2022 (or February 9, 2023, as applicable)
or longer before redemption from our trust account. In addition, our public stockholders may only receive a pro rata portion of the
amount then in the trust account (which may be less than $10.00 per share) on our redemption, and our warrants will expire worthless. |
For
risk factors related to TradeStation and our proposed business combination with TradeStation, please review the Registration Statement
on Form S-4 (File No. 333-261885) filed by TradeStation, including the preliminary proxy statement/prospectus of the Company included
therein, and the definitive proxy statement/prospectus to be filed by the Company.
Risks
Relating to Our Search for, Consummation of, or Inability to Consummate, a Business Combination and Post-Business Combination Risks
We
are a blank check company in the early stage with no operating history and no revenues, and you have no basis on which to evaluate our
ability to achieve our business objective.
We
are a blank check company with no operating results to date. Because we lack an operating history, you have no basis upon which to evaluate
our ability to achieve our business objective of completing our initial business combination with one or more target businesses. We may
be unable to complete our initial business combination, including the proposed business combination with TradeStation. If we fail to
complete our initial business combination, we will never generate any operating revenues.
Our
search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially
adversely affected by the recent coronavirus (COVID-19) outbreak and the status of debt and equity markets.
The COVID-19 outbreak
has resulted, and a significant outbreak of other infectious diseases could result, in a widespread health crisis that has affected, or
could adversely affect, the economies and financial markets worldwide, and the business of any potential target business with which we
consummate a business combination could be materially and adversely affected. Furthermore, we may be unable to complete a business combination
if concerns relating to COVID-19 continue to restrict travel, limit the ability to have meetings with potential investors or the
target company’s personnel, vendors and services providers are unavailable to negotiate and consummate a transaction in a timely
manner. The extent to which COVID-19 impacts our search for a business combination will depend on future developments, which are
highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the
actions to contain COVID-19 or treat its impact, among others. If the disruptions posed by COVID-19 or other matters of global
concern continue for an extensive period of time, our ability to consummate a business combination, such as the proposed business combination
with TradeStation, or the operations of a target business with which we ultimately consummate a business combination, may be materially
adversely affected. In addition, our ability to consummate a transaction may be dependent on the ability to raise equity and debt financing
which may be impacted by COVID-19 and other events, including as a result of increased market volatility, decreased market liquidity
and third-party financing being unavailable on terms acceptable to us or at all. Additionally, financial markets may be adversely
affected by current or anticipated military conflict, including between Russia and Ukraine, terrorism, sanctions or other geopolitical
events globally.
The
requirement that the target business or businesses that we acquire must collectively have a fair market value equal to at least 80% of
the balance of the funds in the trust account (excluding any deferred underwriters’ fees and taxes payable on the income earned
on the trust account) at the time of the execution of a definitive agreement for our initial business combination may limit the type
and number of companies with which we may complete such a business combination.
Pursuant
to NYSE listing rules, the target business or businesses that we acquire must collectively have a fair market value equal to at least
80% of the balance of the funds in the trust account (excluding any deferred underwriters’ fees and taxes payable on the income
earned on the trust account) at the time of the execution of a definitive agreement for our initial business combination. This restriction
may limit the type and number of companies that we may complete a business combination with. If we are unable to locate a target business
or businesses that satisfy this fair market value test, we may be forced to liquidate and you will only be entitled to receive your pro
rata portion of the funds in the trust account, which may be less than $10.00 per share.
Our
public stockholders may not be afforded an opportunity to vote on our proposed business combination, which means we may consummate our
initial business combination even though a majority of our public stockholders do not support such a combination.
If
a stockholder vote is not required, we may conduct redemptions via a tender offer. Accordingly, we may consummate our initial business
combination even if holders of a majority of our public shares do not approve the business combination.
Your
only opportunity to affect the investment decision regarding a potential business combination may be limited to the exercise of your
right to redeem your shares from us for cash.
You
may not be provided with an opportunity to evaluate the specific merits or risks of one or more target businesses. Because our board
of directors may consummate our initial business combination without seeking stockholder approval, public stockholders may not have the
right or opportunity to vote on the business combination. Accordingly, your only opportunity to affect the investment decision regarding
a potential business combination may be limited to exercising your redemption rights within the period of time (which will be at least
20 business days) set forth in our tender offer documents mailed to our public stockholders in which we describe our business combination.
The
ability of our public stockholders to redeem their shares for cash may make our financial condition unattractive to potential business
combination targets, which may make it difficult for us to enter into our initial business combination with a target.
We
may enter into a transaction agreement with a prospective target that requires as a closing condition that we have a minimum net worth
or a certain amount of cash. If too many public stockholders exercise their redemption rights, we may not be able to meet such closing
condition, and, as a result, would not be able to proceed with the business combination. Furthermore, in no event will we redeem our
public shares in an amount that would cause our net tangible assets to be less than $5,000,001. Consequently, if accepting all properly
submitted redemption requests would cause our net tangible assets to be less than $5,000,001, or such greater amount necessary to satisfy
a closing condition as described above, we would not proceed with such redemption and the related business combination and may instead
search for an alternate business combination. Prospective targets would be aware of these risks and, thus, may be reluctant to enter
into our initial business combination transaction with us.
The
ability of a large number of our stockholders to exercise redemption rights may not allow us to consummate the most desirable business
combination or optimize our capital structure.
In
connection with the consummation of our business combination, we may redeem up to that number of shares of common stock that would permit
us to maintain net tangible assets of $5,000,001. If our business combination requires us to use substantially all of our cash to pay
the purchase price, the redemption threshold may be further limited. Alternatively, we may need to arrange third party financing to help
fund our business combination in case a larger percentage of stockholders exercises its redemption rights than we expect. If the acquisition
involves the issuance of our shares as consideration, we may be required to issue a higher percentage of our shares to the target or
its stockholders to make up for the failure to satisfy a minimum cash requirement. Raising additional funds to cover any shortfall may
involve dilutive equity financing or incurring indebtedness at higher than desirable levels. This may limit our ability to effectuate
the most attractive business combination available to us.
The
requirement that we maintain a minimum net worth or retain a certain amount of cash could increase the probability that we cannot consummate
our business combination and that you would have to wait for liquidation in order to redeem your shares.
If,
pursuant to the terms of our proposed business combination, we are required to maintain a minimum net worth or retain a certain amount
of cash in trust in order to consummate the business combination, regardless of whether we proceed with redemptions under the tender
offer or proxy rules, the probability that we cannot consummate our business combination is increased. If we do not consummate our business
combination, you would not receive your pro rata portion of the trust account until we liquidate. If you are in need of immediate liquidity,
you could attempt to sell your shares in the open market; however, at such time our shares may trade at a discount to the pro rata amount
in our trust account. In either situation, you may suffer a material loss on your investment or lose the benefit of funds expected in
connection with a redemption until we liquidate or you are able to sell your shares in the open market.
The
requirement that we complete our initial business combination by August 9, 2022 (or February 9, 2023, as applicable) may give potential
target businesses leverage over us in negotiating our initial business combination.
Any
potential target business with which we enter into negotiations concerning our initial business combination will be aware that we must
consummate our initial business combination by August 9, 2022 (or February 9, 2023, as applicable). Consequently, such target business
may obtain leverage over us in negotiating our initial business combination, knowing that if we do not complete our initial business
combination with that particular target business, we may be unable to complete our initial business combination with any target business.
This risk will increase as we get closer to the timeframe described above. In addition, we may have limited time to conduct due diligence,
and may enter into our initial business combination on terms that we would have rejected upon a more comprehensive investigation.
We
may not be able to consummate our initial business combination within the required time period, in which case we would cease all operations
except for the purpose of winding up and we would redeem our public shares and liquidate.
Our co-sponsors and
our officers and directors have agreed that we must complete our initial business combination by August 9, 2022 (or February 9,
2023, as applicable) if we have executed a letter of intent, agreement in principle or definitive agreement for an initial business combination
by August 9, 2022. We may not be able to find a suitable target business and consummate our initial business combination within
such time period. If we are unable to consummate our initial business combination within the required time period, we will, as promptly
as reasonably possible but not more than five business days thereafter (subject to our certificate of incorporation and Delaware law),
distribute the aggregate amount then on deposit in the trust account (net of taxes payable), pro rata to our public stockholders by way
of redemption and cease all operations except for the purposes of winding up of our affairs, as further described herein. This redemption
of public stockholders from the trust account shall be effected as required by our certificate of incorporation and Delaware law, prior
to any voluntary winding up.
If
we seek stockholder approval of our business combination, our co-sponsors, directors, officers and their affiliates may elect to purchase
shares from stockholders, in which case they may influence a vote in favor of a proposed business combination that you do not support.
If
we seek stockholder approval of our business combination and we do not conduct redemptions in connection with our business combination
pursuant to the tender offer rules, our co-sponsors, directors, officers or their affiliates may purchase shares in privately negotiated
transactions either prior to or following the consummation of our initial business combination. Such purchases will not be made if our
co-sponsors, directors, officers or their affiliates are in possession of any material non-public information that has not been
disclosed to the selling stockholder. Such a purchase would include a contractual acknowledgement that such stockholder, although still
the record holder of our shares, is no longer the beneficial owner thereof and therefore agrees not to exercise its redemption rights.
In the event that our co-sponsors, directors, officers or their affiliates purchase shares in privately negotiated transactions from
public stockholders who have already elected to exercise their redemption rights, such selling stockholders would be required to revoke
their prior elections to redeem their shares. It is intended that, if Rule 10b-18 under the Exchange Act would apply to purchases
by our initial stockholders, directors, officers or their affiliates, then such purchases will comply with Rule 10b-18, to the extent
it applies, which provides a safe harbour for purchased made under certain conditions, including with respect to timing, pricing and
volume of purchases.
The
purpose of such purchases would be to (1) increase the likelihood of obtaining stockholder approval of the business combination
or (2) satisfy a closing condition in an agreement with a target that requires us to have a minimum net worth or a certain amount
of cash at the closing of the business combination, where it appears that such requirement would otherwise not be met. This may result
in the consummation of an initial business combination that may not otherwise have been possible.
Purchases
of shares of common stock in the open market or in privately negotiated transactions by our co-sponsors, directors, officers or
their affiliates may make it difficult for us to maintain the listing of our shares on a national securities exchange following the consummation
of an initial business combination.
If
our co-sponsors, directors, officers or their affiliates purchase shares of common stock in the open market or in privately negotiated
transactions, the public “float” of our shares of common stock and the number of beneficial holders of our securities would
both be reduced, possibly making it difficult to maintain the listing or trading of our securities on a national securities exchange
following consummation of the business combination.
You
will not have any rights or interests in funds from the trust account, except under certain limited circumstances. To liquidate your
investment, therefore, you may be forced to sell your public shares, potentially at a loss.
Our
public stockholders are entitled to receive funds from the trust account only in the event of a redemption to public stockholders prior
to any winding up in the event we do not consummate our initial business combination or our liquidation, if they redeem their shares
in connection with an initial business combination that we consummate, or if we seek to amend our certificate of incorporation to affect
the substance or timing of our redemption obligation to redeem all public shares if we cannot complete an initial business combination
by August 9, 2022 (or February 9, 2023, as applicable). In no other circumstances will a stockholder have any right or interest of any
kind to the funds in the trust account. Accordingly, to liquidate your investment, you may be forced to sell your public shares, potentially
at a loss.
You
are not entitled to protections normally afforded to investors of many other blank check companies.
Because
the net proceeds of the initial public offering are intended to be used to complete our initial business combination with a target business
that has not been identified, we may be deemed to be a “blank check” company under the United States securities laws.
However, because we had net tangible assets in excess of $5,000,000 upon the consummation of the initial public offering and filed a
Current Report on Form 8-K, including an audited balance sheet demonstrating this fact, we are exempt from rules promulgated by
the SEC to protect investors in blank check companies, such as Rule 419. Accordingly, investors are not afforded the benefits or
protections of those rules. Among other things, this means our units were immediately tradable upon consummation of the initial public
offering, and we have a longer period of time to complete our initial business combination than companies have that are subject to Rule 419.
Moreover, offerings subject to Rule 419 would prohibit the release of any interest earned on funds held in the trust account to
us.
If
the net proceeds not being held in the trust account are insufficient to allow us to operate until August 9, 2022 (or February 9, 2023,
as applicable), we may be unable to complete our initial business combination.
The
funds available to us outside of the trust account may not be sufficient to allow us to operate until August 9, 2022 (or February 9,
2023, as applicable), assuming that our initial business combination is not consummated during that time. Of the funds available to us,
we could use a portion of the funds available to us to pay fees to consultants to assist us with our search for a target business. We
could also use a portion of the funds as a down payment or to fund a “no-shop” provision (a provision in letters of intent
designed to keep target businesses from “shopping” around for transactions with other companies on terms more favorable to
such target businesses) with respect to a particular proposed business combination, although we do not have any current intention to
do so. If we are unable to fund such down payments or “no shop” provisions, our ability to close a contemplated transaction
could be impaired. Furthermore, if we entered into a letter of intent where we paid for the right to receive exclusivity from a target
business and were subsequently required to forfeit such funds (whether as a result of our breach or otherwise), we might not have sufficient
funds to continue searching for, or conduct due diligence with respect to, a target business. If we are unable to complete our initial
business combination, our public stockholders may only receive a pro rata portion of the amount then in the trust account (which may
be less than $10.00 per share) on our redemption, and our warrants will expire worthless.
Subsequent
to our consummation of our initial business combination, we may be required to take write-downs or write-offs, restructuring and impairment
or other charges.
Even
if we conduct thorough due diligence on a target business with which we combine, this diligence may not surface all material issues that
may be present inside a particular target business. Even with thorough due diligence, we may not be able to uncover all material issues,
and there may be factors outside of the target business and outside of our control that may arise. As a result of these factors, we may
be forced to later write-down or write-off assets, restructure our operations, or incur impairment or other charges that could
result in our reporting losses. Even if our due diligence successfully identifies certain risks, unexpected risks may arise and previously
known risks may materialize in a manner not consistent with our preliminary risk analysis. Even though these charges may be non-cash items
and not have an immediate impact on our liquidity, the fact that we report charges of this nature could contribute to negative market
perceptions about us or our securities. In addition, charges of this nature may cause us to violate net worth or other covenants to which
we may be subject as a result of assuming pre-existing debt held by a target business or by virtue of our obtaining post-combination debt
financing.
If
third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption price received
by stockholders may be less than $10.00.
Our
placing of funds in the trust account may not protect those funds from third-party claims against us. Although we will seek to have
all vendors, service providers (excluding our independent registered public accounting firm), prospective target businesses and other
entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies
held in the trust account for the benefit of our public stockholders, such parties may not execute such agreements, or even if they execute
such agreements, they may not be prevented from bringing claims against the trust account, including, but not limited to, fraudulent
inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the waiver,
in each case in order to gain advantage with respect to a claim against our assets, including the funds held in the trust account. If
any third-party refuses to execute an agreement waiving such claims to the monies held in the trust account, our management will
perform an analysis of the alternatives available to it and will only enter into an agreement with a third-party that has not executed
a waiver if management believes that such third-party’s engagement would be significantly more beneficial to us than any alternative.
Examples of possible instances where we may engage a third-party that refuses to execute a waiver include the engagement of a third-party consultant
whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would
agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver. In addition,
there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of,
any negotiations, contracts or agreements with us and will not seek recourse against the trust account for any reason. Upon redemption
of our public shares, if we are unable to consummate an initial business combination by August 9, 2022 (or February 9, 2023, as applicable),
or upon the exercise of a redemption right in connection with our initial business combination, we will be required to provide for payment
of claims of creditors that were not waived that may be brought against us within the ten years following redemption. Accordingly, the
per-share redemption amount received by public stockholders could be less than the $10.00 per public share initially held in the
trust account, due to claims of such creditors. Pursuant to a letter agreement, Quantum Ventures has agreed that it will be liable to
us if and to the extent any claims by a third-party (excluding our independent registered public accounting firm) for services rendered
or products sold to us, or a prospective target business with which we have discussed entering into a transaction agreement, reduce the
amounts in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per share held in the
trust account as of the date of the liquidation of the trust account if less than $10.00 per share due to reductions in the value of
the trust assets, in each case less taxes payable, provided that such liability will not apply to any claims by a third-party who
executed a waiver of any and all rights to seek access to the trust account nor will it apply to any claims under our indemnity of the
underwriters of our initial public offering against certain liabilities, including liabilities under the Securities Act. Moreover, in
the event that an executed waiver is deemed to be unenforceable against a third-party, Quantum Ventures will not be responsible to the
extent of any liability for such third-party claims. However, we have not asked Quantum Ventures to reserve for such indemnification
obligations, nor have we independently verified whether Quantum Ventures has sufficient funds to satisfy its indemnity obligations and
we believe that Quantum Ventures’ only assets are securities of our company. Therefore, we cannot assure you that Quantum Ventures
would be able to satisfy those obligations. None of our officers or directors will indemnify us for claims by third parties, including,
without limitation, claims by vendors and prospective target businesses.
Our
directors may decide not to enforce indemnification obligations against Quantum Ventures, resulting in a reduction in the amount of funds
in the trust account available for distribution to our public stockholders.
In
the event that the proceeds in the trust account are reduced below $10.00 per share and Quantum Ventures asserts that it is unable to
satisfy its obligations or that it has no indemnification obligations related to a particular claim, our independent directors would
determine on our behalf whether to take legal action against Quantum Ventures to enforce its indemnification obligations. While we currently
expect that our independent directors would take legal action on our behalf against Quantum Ventures to enforce its indemnification obligations
to us, it is possible that our independent directors in exercising their business judgment may choose not to do so in any particular
instance. If our independent directors choose not to enforce these indemnification obligations on our behalf, the amount of funds in
the trust account available for distribution to our public stockholders may be reduced below $10.00 per share.
If,
after we distribute the proceeds in the trust account to our public stockholders, we file a bankruptcy or winding-up petition or an involuntary
bankruptcy or winding-up petition is filed against us that is not dismissed, a bankruptcy or insolvency court may seek to recover such
proceeds, and the members of our board of directors may be viewed as having breached their fiduciary duties to our creditors, thereby
exposing the members of our board of directors and us to claims of punitive damages.
If,
after we distribute the proceeds in the trust account to our public stockholders, we file a bankruptcy or winding-up petition or
an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed, any distributions received by stockholders
could be viewed under applicable debtor/creditor and/or bankruptcy or insolvency laws as either a “preferential transfer”
or a “fraudulent conveyance.” As a result, a bankruptcy or insolvency court could seek to recover some or all amounts received
by our stockholders. In addition, our board of directors may be viewed as having breached its fiduciary duty to our creditors and/or
having acted in bad faith, thereby exposing itself and us to claims of punitive damages, by paying public stockholders from the trust
account prior to addressing the claims of creditors.
If,
before distributing the proceeds in the trust account to our public stockholders, we file a bankruptcy or winding-up petition or an involuntary
bankruptcy or winding-up petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority
over the claims of our stockholders and the per-share amount that would otherwise be received by our stockholders in connection with
our liquidation may be reduced.
If,
before distributing the proceeds in the trust account to our public stockholders, we file a bankruptcy or winding-up petition or
an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed, the proceeds held in the trust account
could be subject to applicable bankruptcy or insolvency law, and may be included in our bankruptcy estate and subject to the claims of
third parties with priority over the claims of our stockholders. To the extent any bankruptcy claims deplete the trust account, the per-share amount
that would otherwise be received by our stockholders in connection with our liquidation may be reduced.
If
we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements
and our activities may be restricted, which may make it difficult for us to complete our initial business combination.
If
we are deemed to be an investment company under the Investment Company Act, our activities may be restricted, including restrictions
on the nature of our investments and restrictions on the issuance of securities, each of which may make it difficult for us to complete
our initial business combination. In addition, we may have imposed upon us burdensome requirements, including registration as an investment
company, adoption of a specific form of corporate structure and reporting, record keeping, voting, proxy and disclosure requirements
and other rules and regulations.
If
we were deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional
expenses for which we have not allotted funds and may hinder our ability to consummate our initial business combination.
Changes
in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, investments and results
of operations.
We
are subject to laws and regulations enacted by national, regional and local governments and agencies, in particular, the SEC. Compliance
with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those laws and regulations and
their interpretation and application also may change from time to time and those changes could have a material adverse effect on our
business, investments and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted
and applied, could have a material adverse effect on our business and results of operations.
If
we are unable to consummate our initial business combination, our public stockholders may be forced to wait until August 9, 2022 (or
February 9, 2023, as applicable) or longer before redemption from our trust account.
If
we are unable to consummate our initial business combination by August 9, 2022 (or February 9, 2023, as applicable) we will, as promptly
as reasonably possible but not more than five business days thereafter (subject to our certificate of incorporation and applicable law),
distribute the aggregate amount then on deposit in the trust account (net of taxes payable), pro rata to our public stockholders by way
of redemption and cease all operations except for the purposes of winding up of our affairs by way of a voluntary liquidation, as further
described herein. Any redemption of public stockholders from the trust account shall be effected as required by our certificate of incorporation
prior to our commencing any voluntary liquidation. Except as otherwise described herein, we have no obligation to return funds to investors
prior to the date of any redemption required as a result of our failure to consummate our initial business combination within the period
described above or our liquidation, unless we consummate our initial business combination prior thereto and only then in cases where
investors have sought to redeem their shares of common stock. Only upon any such redemption of public shares as we are required to effect
or any liquidation will public stockholders be entitled to distributions if we are unable to complete our initial business combination.
We
are an emerging growth company and a smaller reporting company within the meaning of the Securities Act, and if we take advantage of
certain exemptions from disclosure requirements available to emerging growth companies and smaller reporting companies, this could make
our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.
We
are an “emerging growth company,” as defined in the JOBS Act. We will remain an “emerging growth company” for
up to five years. However, if our non-convertible debt issued within a three-year period or revenues exceeds $1.07 billion,
or the market value of our shares of common stock that are held by non-affiliates exceeds $700 million on the last day of the
second fiscal quarter of any given fiscal year, we would cease to be an emerging growth company as of the following fiscal year. As an
emerging growth company, we are not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act,
we have reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and we are exempt
from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute
payments not previously approved.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of
such extended transition period which means that when a new accounting standard is issued or revised and it has different application
dates for public or private companies, we, as an emerging growth company, will not adopt the new or revised standard until the time private
companies are required to adopt the new or revised standard. This may make comparison of our financial statements with another public
company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition
period difficult or impossible because of the potential differences in accounting standards used. As such, our financial statements may
not be comparable to companies that comply with public company effective dates. We cannot predict if investors will find our shares less
attractive because we may rely on the provisions of the JOBS Act. If some investors find our shares less attractive as a result of, there
may be a less active trading market for our shares and our share price may be more volatile.
Additionally,
we are a “smaller reporting company” as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may
take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial
statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our
common stock held by non-affiliates exceeds $250 million as of the end of that year’s second fiscal quarter, or (2) our
annual revenues exceeded $100 million during such completed fiscal year and the market value of our common stock held by non-affiliates exceeds
$700 million as of the end of that year’s second fiscal quarter. To the extent we take advantage of such reduced disclosure
obligations, it may also make comparison of our financial statements with other public companies difficult or impossible.
We
may face risks related to FinTech or related businesses.
Business
combinations with FinTech or related businesses may involve special considerations and risks. If we complete our initial business combination
with a FinTech or related business, we will be subject to the following risks, any of which could be detrimental to us and the business
we acquire:
|
● |
If the company or business
we acquire provides products or services which relate to the facilitation of financial transactions, such as funds or securities
settlement system, and such product or service fails or is compromised, we may be subject to claims from both the firms to whom we
provide our products and services and the clients they serve; |
|
● |
If we are unable to keep
pace with evolving technology and changes in the financial services industry our revenues and future prospects may decline; |
|
● |
Our ability to provide
FinTech or related products and services to customers may be reduced or eliminated by legal or regulatory changes; |
|
● |
Any business or company
we acquire could be vulnerable to cyberattack or theft of individual identities or personal data; |
|
● |
Difficulties with any products
or services we provide could damage our reputation and business; |
|
● |
A failure to comply with
privacy and other laws and regulations to which we may be subject could adversely affect relations with customers and have a negative
impact on business; |
|
● |
We may not be able to protect
our intellectual property and we may be subject to infringement claims. |
Any
of the foregoing could have an adverse impact on our operations following a business combination. If we acquire a target business in
another industry, these risks will likely not affect us and we will be subject to other risks attendant with the specific industry in
which we operate or target business which we acquire, none of which can be presently ascertained.
If
we were unable to complete the TradeStation Business Combination and have to select another target business with which to pursue our
initial business combination, you will be unable to ascertain the merits or risks of any such other target business’ operations.
We may pursue acquisition
opportunities in any geographic region. While we may pursue an acquisition opportunity in any business industry or sector, we initially
focused our efforts on identifying high-growth financial services and FinTech businesses. Except for the limitations that a target
business have a fair market value of at least 80% of the value of the trust account (excluding any deferred underwriters’ fees
and taxes payable on the income earned on the trust account) and that we are not permitted to effectuate our initial business combination
with another blank check company or similar company with nominal operations, we have flexibility in identifying and selecting a prospective
acquisition candidate. Accordingly, if we were unable to complete the TradeStation Business Combination, there is no basis for you to
evaluate the possible merits or risks of the particular industry in which we may ultimately operate or the target business which we may
ultimately acquire. To the extent we consummate our initial business combination, we may be affected by numerous risks inherent in the
business operations with which we combine. For example, if we combine with a financially unstable business or an entity lacking an established
record of sales or earnings, we may be affected by the risks inherent in the business and operations of a financially unstable or a development
stage entity. Although our officers and directors will endeavor to evaluate the risks inherent in a particular target business, we may
not properly ascertain or assess all of the significant risk factors, or we may not have adequate time to complete due diligence with
respect to the target business and its industry. Furthermore, some of these risks may be outside of our control and leave us with no
ability to control or reduce the chances that those risks will adversely impact a target business. In addition, investors will be relying
on the business judgment of our board of directors, which will have significant discretion in choosing the standard used to establish
the fair market value of a particular target business. An investment in our securities may not ultimately prove to be more favorable
to investors than a direct investment, if such opportunity were available, in an acquisition target.
If
we were unable to complete the TradeStation Business Combination, we could seek investment opportunities outside our management’s
area of expertise and our management may not be able to adequately ascertain or assess all significant risks associated with the target
company.
There
is no limitation on the industry or business sector we may consider when contemplating our initial business combination. We may therefore
be presented with a business combination candidate in an industry unfamiliar to our management team, but determine that such candidate
offers an attractive investment opportunity for our company. In the event we elect to pursue an investment outside of our management’s
expertise, our management’s experience may not be directly applicable to the target business or the evaluation of its operations.
Although
we identified general criteria and guidelines that we believe are important in evaluating prospective target businesses, if we are unable
to complete the TradeStation Business Combination, we may enter into our initial business combination with a target that does not meet
such criteria and guidelines, and, as a result, the target business with which we enter into our initial business combination may not
have attributes entirely consistent with our general criteria and guidelines.
Although we have identified
specific criteria and guidelines for evaluating prospective target businesses, it is possible that a target business, with which we enter
into our initial business combination will not have all of these attributes. If we consummate our initial business combination with a
target that does not meet some or all of these guidelines, such combination may not be as successful as a combination with a business
that does meet all of our general criteria and guidelines. In addition, if we announce our initial business combination with a target
that does not meet our general criteria and guidelines, a greater number of stockholders may exercise its redemption rights, which may
make it difficult for us to meet any closing condition with a target business that requires us to have a minimum net worth or a certain
amount of cash. In addition, if stockholder approval of the transaction is required by law or the NYSE, or we decide to obtain stockholder
approval for business or other legal reasons, it may be more difficult for us to attain stockholder approval of our initial business
combination if the target business does not meet our general criteria and guidelines. If we are unable to complete our initial business
combination, our public stockholders may only receive $10.00 per share or even less on our redemption, and our warrants will expire worthless.
As
the number of special purpose acquisition companies evaluating targets increases, attractive targets may become scarcer and there may
be more competition for attractive targets. This could increase the cost of our initial business combination and could even result in
our inability to find a target or to consummate an initial business combination.
In
recent years, the number of special purpose acquisition companies that have been formed has increased substantially. Many potential targets
for special purpose acquisition companies have already entered into an initial business combination, and there are still many special
purpose acquisition companies seeking targets for their initial business combination, as well as many such companies currently in registration.
As a result, at times, fewer attractive targets may be available, and it may require more time, more effort and more resources to identify
a suitable target and to consummate an initial business combination.
In
addition, because there are more special purpose acquisition companies seeking to enter into an initial business combination with available
targets, the competition for available targets with attractive fundamentals or business models may increase, which could cause targets
companies to demand improved financial terms. Attractive deals could also become scarcer for other reasons, such as economic or industry
sector downturns, geopolitical tensions, or increases in the cost of additional capital needed to close business combinations or operate
targets post-business combination. This could increase the cost of, delay or otherwise complicate or frustrate our ability to find and
consummate an initial business combination, and may result in our inability to consummate an initial business combination on terms favorable
to our investors altogether.
Changes
in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and
complete an initial business combination.
In
recent months, the market for directors and officers liability insurance for special purpose acquisition companies has changed. Fewer
insurance companies are offering quotes for directors and officers liability coverage, the premiums charged for such policies have generally
increased and the terms of such policies have generally become less favorable. There can be no assurance that these trends will not continue.
The
increased cost and decreased availability of directors and officers liability insurance could make it more difficult and more expensive
for us to negotiate an initial business combination. In order to obtain directors and officers liability insurance or modify its coverage
as a result of becoming a public company, the post-business combination entity might need to incur greater expense, accept less favorable
terms or both. However, any failure to obtain adequate directors and officers liability insurance could have an adverse impact on the
post-business combination’s ability to attract and retain qualified officers and directors.
In
addition, even after we were to complete an initial business combination, our directors and officers could still be subject to potential
liability from claims arising from conduct alleged to have occurred prior to the initial business combination. As a result, in order
to protect our directors and officers, the post-business combination entity may need to purchase additional insurance with respect to
any such claims (“run-off insurance”). The need for run-off insurance would be an added expense for the post-business combination
entity, and could interfere with or frustrate our ability to consummate an initial business combination on terms favorable to our investors.
We
are not required to obtain an opinion from an independent investment banking firm in connection with a business combination, and consequently,
an independent source may not confirm that the price we are paying for the business is fair to our public stockholders from a financial
point of view.
Unless
we consummate our initial business combination with an affiliated entity, we are not required to obtain an opinion from an independent
investment banking firm that the price we are paying is fair to our public stockholders from a financial point of view. If no opinion
is obtained, our stockholders will be relying on the judgment of our board of directors, who will determine fair market value based on
standards generally accepted by the financial community. Such standards used will be disclosed in our tender offer documents or proxy
solicitation materials, as applicable, related to our initial business combination.
Resources
could be wasted in researching acquisitions that are not consummated.
We
anticipate that the investigation of each specific target business and the negotiation, drafting, and execution of relevant agreements,
disclosure documents, and other instruments will require substantial management time and attention and substantial costs for accountants,
attorneys and others. If we decide not to complete a specific initial business combination, the costs incurred up to that point for the
proposed transaction likely would not be recoverable. Furthermore, if we reach an agreement relating to a specific target business, we
may fail to consummate our initial business combination for any number of reasons including those beyond our control. Any such event
will result in a loss to us of the related costs incurred, which could materially adversely affect subsequent attempts to locate and
acquire or merge with another business. If we are unable to complete our initial business combination, our public stockholders may only
receive $10.00 per share or even less on our redemption, and our warrants will expire worthless.
We
may be unable to obtain additional financing to complete our initial business combination or to fund the operations and growth of a target
business, which could compel us to restructure or abandon a particular business combination. If we are unable to complete our initial
business combination, our public stockholders may only receive $10.00 per share or even less on our redemption, and the warrants will
expire worthless.
If the net proceeds of our
initial public offering prove to be insufficient, either because of the size of our initial business combination, the depletion of the
available net proceeds in search of a target business, the obligation to repurchase for cash a significant number of shares from stockholders
who elect redemption in connection with our initial business combination or the terms of negotiated transactions to purchase shares in
connection with our initial business combination, we may be required to seek additional financing or to abandon the proposed business
combination. Financing may not be available on acceptable terms, if at all. In addition, pursuant to the Merger Agreement, we cannot borrow
amounts over $500,000 unless we receive approval from TradeStation. The current economic environment, including due to the effects of
the COVID-19 pandemic, has made it especially difficult for companies to obtain acquisition financing. To the extent that additional
financing proves to be unavailable when needed to consummate our initial business combination, we would be compelled to either restructure
the transaction or abandon that particular initial business combination and seek an alternative target business candidate. If we are unable
to complete our initial business combination, our public stockholders may only receive $10.00 per share or even less on our redemption,
and the warrants will expire worthless. In addition, even if we do not need additional financing to consummate our initial business combination,
we may require such financing to fund the operations or growth of the target business. The failure to secure additional financing could
have a material adverse effect on the continued development or growth of the target business. None of our officers, directors or stockholders
is required to provide any financing to us in connection with or after our initial business combination.
Our independent registered public accounting
firm’s report contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a “going concern.”
As of December 31, 2021,
we have incurred and expect to continue to incur significant costs in pursuit of our financing and acquisition plans. We cannot
assure you that our plans to raise capital or to consummate an initial business combination will be successful. If we are unable to raise
additional funds to alleviate liquidity needs and complete a business combination by February 9, 2023, then we will cease all operations
except for the purpose of liquidating. Quantum Ventures has committed to provide us up to $3,000,000 in Working Capital Loans (as defined
below), however, pursuant to the Merger Agreement, we need approval from TradeStation to borrow amounts over $500,000, so we may not be
able to utilize the Working Capital Loan commitments or obtain additional financing. The liquidity condition and date for mandatory liquidation
and subsequent dissolution raise substantial doubt about our ability to continue as a going concern. Management intends to complete an
initial business combination before February 9, 2023, however, it is uncertain whether management will succeed in doing so. The restated
financial statements contained elsewhere in this Amendment do not include any adjustments that might result from our inability to continue
as a going concern.
We
may only be able to complete one business combination with the proceeds of our initial public offering, which will cause us to be solely
dependent on a single business, which may have a limited number of products or services. This lack of diversification may negatively
impact our operations and profitability.
We
may effectuate our initial business combination with a single target business or multiple target businesses simultaneously. However,
we may not be able to effectuate our initial business combination with more than one target business because of various factors, including
the existence of complex accounting issues and the requirement that we prepare and file pro forma financial statements with the SEC that
present operating results and the financial condition of several target businesses as if they had been operated on a combined basis.
By consummating our initial business combination with only a single entity, our lack of diversification may subject us to numerous economic,
competitive and regulatory developments. Further, we would not be able to diversify our operations or benefit from the possible spreading
of risks or offsetting of losses, unlike other entities, which may have the resources to complete several business combinations in different
industries or different areas of a single industry. Accordingly, the prospects for our success may be solely dependent upon the performance
of a single business, property or asset, or dependent upon the development or market acceptance of a single or limited number of products
or services. This lack of diversification may subject us to numerous economic, competitive and regulatory developments, any or all of
which may have a substantial adverse impact upon the particular industry in which we may operate subsequent to our initial business combination.
If
we are unable to complete the TradeStation Business Combination, we may attempt to simultaneously consummate business combinations with
multiple prospective targets, which may hinder our ability to consummate our initial business combination and give rise to increased
costs and risks that could negatively impact our operations and profitability.
If
we determine to simultaneously acquire several businesses that are owned by different sellers, we will need for each of such sellers
to agree that our purchase of its business is contingent on the simultaneous closings of the other business combinations, which may make
it more difficult for us, and delay our ability, to complete the initial business combination. With multiple business combinations, we
could also face additional risks, including additional burdens and costs with respect to possible multiple negotiations and due diligence
investigations (if there are multiple sellers) and the additional risks associated with the subsequent assimilation of the operations
and services or products of the acquired companies in a single operating business. If we are unable to adequately address these risks,
it could negatively impact our profitability and results of operations.
If
we are unable to complete the TradeStation Business Combination, we may attempt to consummate our initial business combination with a
private company about which little information is available.
In
pursuing our acquisition strategy, we may seek to effectuate our initial business combination with a privately held company. By definition,
very little public information exists about private companies, and we could be required to make our decision on whether to pursue a potential
initial business combination on the basis of limited information, which may result in our initial business combination with a company
that is not as profitable as we suspected, if at all.
We
may not be able to maintain control of a target business after our initial business combination.
If we are unable to complete
the TradeStation Business Combination, we may structure our initial business combination to acquire less than 100% of the equity interests
or assets of a target business, but we will only consummate such business combination if we will become the majority stockholder of the
target (or control the target through contractual arrangements in limited circumstances for regulatory compliance purposes) or are otherwise
not required to register as an investment company under the Investment Company Act, or to the extent permitted by law we may acquire
interests in a variable interest entity, in which we may have less than a majority of the voting rights in such entity, but in which
we are the primary beneficiary. Even though we may own a majority interest in the target, our stockholders prior to the business combination
may collectively own a minority interest in the post-business combination company, depending on valuations ascribed to the target
and us in the business combination transaction. For example, we could pursue a transaction in which we issue a substantial number of
new shares in exchange for all of the outstanding capital stock of a target. In this case, we acquire a 100% controlling interest in
the target. However, as a result of the issuance of a substantial number of new shares, our stockholders immediately prior to such transaction
could own less than a majority of our outstanding shares subsequent to such transaction. In addition, other minority stockholders may
subsequently combine their holdings resulting in a single person or group obtaining a larger share of the company’s stock than
we initially acquired. Accordingly, this may make it more likely that we will not be able to maintain our control of the target business.
Because
of our structure, other companies may have a competitive advantage and we may not be able to consummate an attractive business combination.
We
expect to encounter intense competition from entities other than blank check companies having a business objective similar to ours, including
venture capital funds, leveraged buyout funds and operating businesses competing for acquisitions. Many of these entities are well established
and have extensive experience in identifying and effecting business combinations directly or through affiliates. Many of these competitors
possess greater technical, human and other resources than we do, and our financial resources will be relatively limited when contrasted
with those of many of these competitors. Therefore, our ability to compete in acquiring certain sizable target businesses may be limited
by our available financial resources. This inherent competitive limitation gives others an advantage in pursuing the acquisition of certain
target businesses. Furthermore, seeking stockholder approval of our initial business combination may delay the consummation of a transaction.
Any of the foregoing may place us at a competitive disadvantage in successfully negotiating our initial business combination.
Cyber
incidents or attacks directed at us could result in information theft, data corruption, operational disruption and/or financial loss.
We
depend on digital technologies, including information systems, infrastructure and cloud applications and services, including those of
third parties with which we may deal. Sophisticated and deliberate attacks on, or security breaches in, our systems or infrastructure,
or the systems or infrastructure of third parties or the cloud, could lead to corruption or misappropriation of our assets, proprietary
information and sensitive or confidential data. As an early stage company without significant investments in data security protection,
we may not be sufficiently protected against such occurrences. We may not have sufficient resources to adequately protect against, or
to investigate and remediate any vulnerability to, cyber incidents. It is possible that any of these occurrences, or a combination of
them, could have adverse consequences on our business and lead to financial loss.
Because
we must furnish our stockholders with target business financial statements prepared in accordance with U.S. GAAP or IFRS, we may lose
the ability to complete an otherwise advantageous initial business combination with some prospective target businesses.
The
federal proxy rules, which require that a proxy statement with respect to a vote on a business combination meeting certain financial
significance tests include historical and/or pro forma financial statement disclosure in periodic reports. These financial statements
may be required to be prepared in accordance with, or be reconciled to, U.S. GAAP or IFRS, depending on the circumstances, and the historical
financial statements may be required to be audited in accordance with PCAOB standards. We will include substantially the same financial
statement disclosure in connection with any tender offer documents we use, whether or not they are required under the tender offer rules.
These financial statement requirements may limit the pool of potential target businesses we may consummate our initial business combination
with because some targets may be unable to provide such statements in time for us to disclose such statements in accordance with federal
proxy rules and complete our initial business combination within the prescribed time frame.
Compliance
obligations under the Sarbanes-Oxley Act of 2002 may make it more difficult for us to effectuate our initial business combination, require
substantial financial and management resources, and increase the time and costs of completing an acquisition.
Section 404
of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, requires that we evaluate and report on our system of internal
controls beginning with our Annual Report on Form 10-K for the year ending December 31, 2021. The fact that we are a blank
check company makes compliance with the requirements of the Sarbanes-Oxley Act particularly burdensome on us because a target company
with which we seek to complete our initial business combination may not be in compliance with the provisions of the Sarbanes-Oxley Act
regarding adequacy of its internal controls. The development of the internal controls of any such entity to achieve compliance with the
Sarbanes-Oxley Act may increase the time and costs necessary to complete any such acquisition.
RISKS
RELATING TO OUR CO-SPONSORS AND MANAGEMENT TEAM
Management’s
flexibility in identifying and selecting a prospective acquisition candidate, along with our management’s financial interest in
consummating our initial business combination, may lead management to enter into an acquisition agreement that is not in the best interest
of our stockholders.
Subject
to the requirement that our initial business combination must be with one or more target businesses or assets having an aggregate fair
market value of at least 80% of the value of the trust account (excluding any deferred underwriters’ fees and taxes payable on
the income earned on the trust account) at the time of the agreement to enter into such initial business combination, we will have virtually
unrestricted flexibility in identifying and selecting a prospective acquisition candidate. Investors will be relying on management’s
ability to identify business combinations, evaluate their merits, conduct or monitor diligence and conduct negotiations. Management’s
flexibility in identifying and selecting a prospective acquisition candidate, along with management’s financial interest in consummating
our initial business combination, may lead management to enter into an acquisition agreement that is not in the best interest of our
stockholders, which would be the case if the trading price of our shares of common stock after giving effect to such business combination
was less than the per-share trust liquidation value that our stockholders would have received if we had dissolved without consummating
our initial business combination.
Our
ability to successfully effect our initial business combination and to be successful thereafter will be largely dependent upon the efforts
of our officers, directors and key personnel, some of whom may join us following our initial business combination.
Our
operations are dependent upon a relatively small group of individuals and, in particular, our officers and directors. We believe that
our success depends on the continued service of our officers and directors, at least until we have consummated our initial business combination.
In addition, our officers and directors are not required to commit any specified amount of time to our affairs, and, accordingly, will
have conflicts of interest in allocating management time among various business activities, including identifying potential business
combinations and monitoring the related due diligence. We do not have an employment agreement with, or key-man insurance on the
life of, any of our directors or officers. The unexpected loss of the services of one or more of our directors or officers could have
a detrimental effect on us.
The
role of such persons in the target business, however, cannot presently be ascertained. Although some of such persons may remain with
the target business in senior management or advisory positions following our initial business combination, it is likely that some or
all of the management of the target business will remain in place. While we intend to closely scrutinize any individuals we engage after
our initial business combination, our assessment of these individuals may not prove to be correct. These individuals may be unfamiliar
with the requirements of operating a company regulated by the SEC, which could cause us to have to expend time and resources helping
them become familiar with such requirements.
Our
key personnel may negotiate employment or consulting agreements with a target business in connection with a particular business combination.
These agreements may provide for them to receive compensation following our initial business combination and, as a result, may cause
them to have conflicts of interest in determining whether a particular business combination is the most advantageous.
Our
key personnel may be able to remain with us after the consummation of our initial business combination only if they are able to negotiate
employment or consulting agreements in connection with the business combination. Such negotiations would take place simultaneously with
the negotiation of the business combination and, could provide for such individuals to receive compensation in the form of cash payments
and/or our securities for services they would render to us after the consummation of the business combination. The personal and financial
interests of such individuals may influence their motivation in identifying and selecting a target business. However, we believe the
ability of such individuals to remain with us after the consummation of our initial business combination will not be the determining
factor in our decision as to whether or not we will proceed with any potential business combination. There is no certainty, however,
that any of our key personnel will remain with us after the consummation of our initial business combination. Our key personnel may not
remain in senior management or advisory positions with us. The determination as to whether any of our key personnel will remain with
us will be made at the time of our initial business combination.
We
may have a limited ability to assess the management of a prospective target business and, as a result, may effectuate our initial business
combination with a target business whose management may not have the skills, qualifications or abilities to manage a public company.
When
evaluating the desirability of effecting our initial business combination with a prospective target business, our ability to assess the
target business’ management may be limited due to a lack of time, resources or information. Our assessment of the capabilities
of the target’s management, therefore, may prove to be incorrect, and such management may lack the expected skills, qualifications
or abilities. Should the target’s management not possess the skills, qualifications or abilities necessary to manage a public company,
the operations and profitability of the post-combination business may be negatively impacted.
The
officers and directors of an acquisition candidate may resign upon consummation of our initial business combination. The loss of an acquisition
target’s key personnel could negatively impact the operations and profitability of our post-combination business.
The
role of an acquisition candidate’s key personnel upon the consummation of our initial business combination cannot be ascertained
at this time. Although we contemplate that certain members of an acquisition candidate’s management team will remain associated
with the acquisition candidate following our initial business combination, it is possible that some members of the management team of
an acquisition candidate will not wish to remain in place.
Past
performance by our management team or their respective affiliates may not be indicative of future performance of an investment in us.
Information
regarding performance is presented for informational purposes only. Any past experience or performance of our management team and their
respective affiliates is not a guarantee of either (i) our ability to successfully identify and execute a transaction or (ii) success
with respect to any business combination that we may consummate. You should not rely on the historical record of our management team
or their respective affiliates as indicative of the future performance of an investment in us or the returns we will, or are likely to,
generate going forward.
Certain
of our officers and directors are affiliated with entities engaged in business activities similar to those intended to be conducted by
us and, accordingly, may have conflicts of interest in allocating their time and determining to which entity a particular business opportunity
should be presented.
Certain
of our executive officers and directors are affiliated with entities that are engaged in a similar business to us. Our officers and directors
may become aware of business opportunities which may be appropriate for presentation to us and the other entities to which they owe certain
fiduciary duties. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should
be presented.
For
example, Mr. Korhammer, our director, is affiliated with Chardan, which was also the underwriter in our initial public offering.
Mr. Korhammer owes a pre-existing fiduciary duty to Chardan, meaning that he may present opportunities to Chardan prior to
presenting them to us, if, for example, a potential target company is open to either raising funds in an offering or engaging in a transaction
with a blank check company. This may limit the number of potential targets Mr. Korhammer presents to us for purposes of completing
a business combination.
Any
conflict of interest may not be resolved in our favor, and potential target businesses may be presented to another entity prior to their
presentation to us.
Certain
shares beneficially owned by our officers and directors will not participate in liquidation distributions and, therefore, our officers
and directors may have a conflict of interest in determining whether a particular target business is appropriate for our initial business
combination.
Our
officers and directors have waived their right to redeem any shares in connection with our initial business combination, or to receive
distributions with respect to their founder shares upon our liquidation if we are unable to consummate our initial business combination.
Accordingly, these securities will be worthless if we do not consummate our initial business combination. Any warrants they hold, like
those held by the public, will also be worthless if we do not consummate an initial business combination. The personal and financial
interests of our directors and officers may influence their motivation in timely identifying and selecting a target business and completing
a business combination. Consequently, our directors’ and officers’ discretion in identifying and selecting a suitable target
business may result in a conflict of interest when determining whether the terms, conditions and timing of a particular business combination
are appropriate and in our stockholders’ best interest.
We
may engage in our initial business combination with one or more target businesses that have relationships with entities that may be affiliated
with our executive officers, directors or existing holders, which may raise potential conflicts of interest.
We
have not adopted a policy that expressly prohibits our directors, officers, security holders or affiliates from having a direct or indirect
pecuniary or financial interest in any investment to be acquired or disposed of by us or in any transaction to which we are a party or
have an interest. In light of the involvement of our co-sponsors, officers and directors with other entities, we may decide to acquire
one or more businesses affiliated with our co-sponsors, officers and directors. Our directors also serve as officers and board members
for other entities. We would pursue a transaction with an entity affiliated with our co-sponsors, officers or directors if we determined
that such affiliated entity met our criteria for our initial business combination and such transaction was approved by a majority of
our disinterested directors. Despite our agreement to obtain an opinion in connection with such transaction from an independent investment
banking firm, or another independent entity that commonly renders valuation opinions on the type of target business we seek to acquire,
regarding the fairness to our stockholders from a financial point of view of a business combination with one or more domestic or international
businesses affiliated with our executive officers, directors or existing holders, potential conflicts of interest still may exist and,
as a result, the terms of the business combination may not be as advantageous to our public stockholders as they would be absent any
conflicts of interest. Our directors have a fiduciary duty to act in the best interests of our stockholders, whether or not a conflict
of interest may exist.
Because
our co-sponsors will lose their entire initial investment in us if our initial business combination is not consummated and our officers
and directors have significant financial interests in us, a conflict of interest may arise in determining whether a particular acquisition
target is appropriate for our initial business combination.
On
October 23, 2020, Quantum Ventures purchased 4,312,500 founder shares from us for $25,000, or $0.006 per share. In January 2021,
Quantum Ventures sold 813,500 founder shares to Chardan Quantum and 35,000 founder shares to each of our directors, in each case at the
original price per share, resulting in Quantum Ventures holding a balance of 3,254,000 founder shares. On February 4, 2021, we effected
a stock dividend of 718,750 shares with respect to our common stock, resulting in our initial stockholders holding an aggregate
of 5,031,250 founder shares. The founder shares will be worthless if we do not consummate an initial business combination. In addition,
Quantum Ventures purchased from us 4,922,500 private warrants and Chardan Quantum purchased from us 1,230,625 private warrants, in each
case, at a price of $1.00 per warrant, for an aggregate purchase price of $6,153,125 in private placements that closed simultaneously
with the closing of our initial public offering. The founder shares and private warrants will be worthless if we do not consummate an
initial business combination.
RISKS
RELATING TO OUR SECURITIES
The
securities in which we invest the funds held in the trust account could bear a negative rate of interest, which could reduce the value
of the assets held in trust such that the per-share redemption amount received by public shareholders may be less than $10.00 per share.
The
proceeds held in the trust account may be invested only in U.S. government treasury obligations with a maturity of 185 days or less
or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in
direct U.S. government treasury obligations. While short-term U.S. government treasury obligations currently yield a positive rate
of interest, they have briefly yielded negative interest rates in recent years. Central banks in Europe and Japan pursued interest rates
below zero in recent years, and the Open Market Committee of the Federal Reserve has not ruled out the possibility that it may in the
future adopt similar policies in the United States. In the event that we are unable to complete our initial business combination
or make certain amendments to our amended and restated memorandum and articles of association, our public shareholders are entitled to
receive their pro-rata share of the proceeds held in the trust account, plus any interest income, net of taxes paid or payable (less,
in the case we are unable to complete our initial business combination, $100,000 of interest). Negative interest rates could reduce the
value of the assets held in trust such that the per-share redemption amount received by public shareholders may be less than $10.00
per share.
We
may issue notes or other debt securities, or otherwise incur substantial debt, to complete our initial business combination, which may
adversely affect our financial condition and thus negatively impact the value of our stockholders’ investment in us.
We
may choose to incur substantial debt to complete our initial business combination. If we incur any indebtedness without a waiver from
any lender of any right, title, interest or claim of any kind in or to any monies held in the trust account, the incurrence of debt could
have a variety of negative effects, including:
|
● |
default and foreclosure
on our assets if our operating revenues after our initial business combination are insufficient to repay our debt obligations; |
|
● |
acceleration of our obligations
to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require
the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
|
● |
our immediate payment of
all principal and accrued interest, if any, if the debt security is payable on demand; |
|
● |
our inability to obtain
necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the
debt security is outstanding; |
|
● |
our inability to pay dividends
on our shares of common stock; |
|
● |
using a substantial portion
of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our shares of
common stock if declared, expenses, capital expenditures, acquisitions and other general corporate purposes; |
|
● |
limitations on our flexibility
in planning for and reacting to changes in our business and in the industry in which we operate; |
|
● |
increased vulnerability
to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
|
● |
limitations on our ability
to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy
and other purposes and other disadvantages compared to our competitors who have less debt. |
If
we seek stockholder approval of our business combination and we do not conduct redemptions pursuant to the tender offer rules, and if
you or a “group” of stockholders are deemed to hold in excess of 20% of our shares of common stock, you will lose the ability
to redeem all such shares in excess of 20% of our shares of common stock.
If
we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our business combination
pursuant to the tender offer rules, our certificate of incorporation provides that a public stockholder, individually or together with
any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as
defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an aggregate
of 20% of the shares sold in our initial public offering. Your inability to redeem more than an aggregate of 20% of the shares sold in
the initial public offering will reduce your influence over our ability to consummate our initial business combination and you could
suffer a material loss on your investment in us if you sell such excess shares in open market transactions. As a result, you will continue
to hold that number of shares exceeding 20% and, in order to dispose of such shares, you would be required to sell your shares in open
market transaction, potentially at a loss.
Holders
of warrants will not participate in liquidating distributions if we are unable to complete an initial business combination within the
required time period.
If
we are unable to complete an initial business combination within the required time period and we liquidate the funds held in the trust
account, the warrants will expire and holders will not receive any of such proceeds with respect to the warrants. The foregoing may provide
a financial incentive to public stockholders to vote in favor of any proposed initial business combination as each of their warrants
would entitle the holder to receive or purchase additional shares of common stock, resulting in an increase in their overall economic
stake in us. If a business combination is not approved, the warrants will expire and be worthless.
If
we do not maintain a current and effective prospectus relating to the shares of common stock issuable upon exercise of the warrants,
public holders will only be able to exercise such warrants on a “cashless basis” which would result in a fewer number of
shares being issued to the holder had such holder exercised the warrants for cash.
If
we do not maintain a current and effective prospectus relating to the shares of common stock issuable upon exercise of the public warrants
at the time that holders wish to exercise such warrants, they will only be able to exercise them on a “cashless basis” provided
that an exemption from registration is available. As a result, the number of shares of common stock that a holder will receive upon exercise
of its public warrants will be fewer than it would have been had such holder exercised its warrant for cash. Further, if an exemption
from registration is not available, holders would not be able to exercise their warrants on a cashless basis and would only be able to
exercise their warrants for cash if a current and effective prospectus relating to the shares of common stock issuable upon exercise
of the warrants is available. Under the terms of the warrant agreement, we agreed to use our best efforts to meet these conditions and
to maintain a current and effective prospectus relating to the shares of common stock issuable upon exercise of the warrants until the
expiration of the warrants. However, we cannot assure you that we will be able to do so. If we are unable to do so, the potential benefit
of the holder’s investment in us may be reduced or the warrants may expire worthless. Notwithstanding the foregoing, the private
warrants may be exercisable for unregistered shares of common stock for cash even if the prospectus relating to the shares of common
stock issuable upon exercise of the warrants is not current and effective.
An
investor will only be able to exercise a warrant for cash if the issuance of common stock upon such exercise has been registered or qualified
or is deemed exempt under the securities laws of the state of residence of the holder of the warrants.
No
public warrants will be exercisable for cash, and we will not be obligated to issue shares of common stock unless the shares of common
stock issuable upon such exercise has been registered or qualified or deemed to be exempt under the securities laws of the state of residence
of the holder of the warrants. At the time that the warrants become exercisable, we expect to continue to be listed on a national securities
exchange, which would provide an exemption from registration in every state. However, we cannot assure you of this fact. If the shares
of common stock issuable upon exercise of the warrants are not qualified or exempt from qualification in the jurisdictions in which the
holders of the warrants reside, the warrants may be deprived of any value, the market for the warrants may be limited and they may expire
worthless if they cannot be sold.
Our
management’s ability to require holders of our warrants to exercise such warrants on a cashless basis will cause holders to receive
fewer shares of common stock upon their exercise of the warrants than they would have received had they been able to exercise their warrants
for cash.
If
we call our public warrants for redemption after the redemption criteria described elsewhere in this Annual Report have been satisfied,
our management will have the option to require any holder that wishes to exercise his warrant (including any warrants held by our co-sponsors and/or
their permitted transferees) to do so on a “cashless basis.” If our management chooses to require holders to exercise their
warrants on a cashless basis, the number of shares of common stock received by a holder upon exercise will be fewer than it would have
been had such holder exercised his warrant for cash. This will have the effect of reducing the potential benefit of the holder’s
investment in our company.
We
may amend the terms of the warrants in a way that may be adverse to holders with the approval by the holders of a majority of the then
outstanding warrants.
Our
warrants were issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant
agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure
any ambiguity or correct any defective provision. The warrant agreement requires the approval by the holders of a majority of the then
outstanding warrants (including the private warrants) in order to make any change that adversely affects the interests of the registered
holders.
We
have no obligation to net cash settle the warrants.
In
no event will we have any obligation to net cash settle the warrants. Accordingly, the warrants may expire worthless.
A
public stockholder who fails to vote either in favor of or against a proposed business combination may not be able to have his, her or
its shares redeemed for cash.
In
order for a public stockholder to have his, her or its shares redeemed for cash in connection with any proposed business combination,
we may require that the public stockholder vote either in favor of or against a proposed business combination. If required to vote pursuant
to the procedures specified in our proxy statement to stockholders relating to the business combination, and such public stockholder
fails to vote in favor of or against the proposed business combination, whether that stockholder abstains from the vote or simply does
not vote, that stockholder would not be able to have his, her or its shares of common stock redeemed for cash in connection with such
business combination.
We
will require public stockholders who wish to redeem their shares of common stock in connection with a proposed business combination or
amendment to our certificate of incorporation to effect the substance or timing of their redemption obligation, if we fail to timely
complete a business combination to comply with specific requirements for redemption that may make it more difficult for them to exercise
their redemption rights prior to the deadline for exercising their rights.
We
will require our public stockholders seeking to exercise their redemption rights, whether they are record holders or hold their shares
in “street name,” to either tender their certificates to our transfer agent prior to the expiration date set forth in the
tender offer documents mailed to such holders, or in the event we distribute proxy materials, up to two business days prior to the vote
on the proposal to approve the business combination or amendment to our certificate of incorporation to affect the substance or timing
of our redemption obligation to redeem all public shares if we cannot complete an initial business combination, or to deliver their shares
to the transfer agent electronically using Depository Trust Company’s DWAC (Deposit/Withdrawal At Custodian) System, at the holder’s
option. In order to obtain a physical stock certificate, a stockholder’s broker and/or clearing broker, DTC and our transfer agent
will need to act to facilitate this request. It is our understanding that stockholders should generally allot at least two weeks to obtain
physical certificates from the transfer agent. However, because we do not have any control over this process or over the brokers or DTC,
it may take significantly longer than two weeks to obtain a physical stock certificate. While we have been advised that it takes a short
time to deliver shares through the DWAC System, this may not be the case. Under Delaware law, we are required to provide at least 10 days’
advance notice of any stockholder meeting, which would be the minimum amount of time a stockholder would have to determine whether to
exercise redemption rights. Accordingly, if it takes longer than we anticipate for stockholders to deliver their shares, stockholders
who wish to redeem may be unable to meet the deadline for exercising their redemption rights and thus may be unable to redeem their shares.
Redeeming
stockholders may be unable to sell their securities when they wish to in the event that the proposed business combination is not approved.
We
will require public stockholders who wish to redeem their shares of common stock in connection with any proposed business combination
to comply with the delivery requirements discussed above for redemption. If such proposed business combination is not consummated, we
will promptly return such certificates to the tendering public stockholders. Accordingly, investors who attempted to redeem their shares
in such a circumstance will be unable to sell their securities after the failed acquisition until we have returned their securities to
them. The market price for our shares of common stock may decline during this time, and you may not be able to sell your securities when
you wish, even while other stockholders that did not seek redemption may be able to sell their securities.
Our
certificate of incorporation contains provisions that prohibit our engaging in business combinations with interested stockholders in
certain circumstances.
We
have opted out of Section 203 of the Delaware General Corporate Law, or the DGCL. However, our certificate of incorporation contains
similar provisions providing that we may not engage in certain “business combinations” with any “interested stockholder”
for a three-year period following the time that the stockholder became an interested stockholder, unless
|
● |
prior to such time, our
board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested
stockholder; |
|
● |
upon consummation of the
transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of
our voting stock outstanding at the time the transaction commenced, excluding certain shares; or |
|
● |
at or subsequent to that
time, the business combination is approved by our board of directors and by the affirmative vote of holders of at least 66⅔%
of the outstanding voting stock that is not owned by the interested stockholder. |
Generally,
a “business combination” includes a merger, asset or stock sale or certain other transactions with the interested stockholder.
Subject to certain exceptions, an “interested stockholder” is a person who, together with that person’s affiliates
and associates, owns, or within the previous three years owned, 20% or more of our voting stock.
Under
certain circumstances, this provision will make it more difficult for a person who would be an “interested stockholder” to
effect various business combinations with a corporation for a three-year period. This provision may encourage companies interested
in acquiring our company to negotiate in advance with our board of directors because the stockholder approval requirement would be avoided
if our board of directors approves either the business combination or the transaction which results in the stockholder becoming an interested
stockholder. These provisions also may have the effect of preventing changes in our board of directors and may make it more difficult
to accomplish transactions which stockholders may otherwise deem to be in their best interests.
Our
certificate of incorporation provides that our co-sponsors, and their respective affiliates, any of their respective direct or indirect
transferees of at least 20% of our outstanding common stock and any group as to which such persons are party to, do not constitute “interested
stockholders” for purposes of this provision.
Our
initial stockholders control a substantial interest in us and thus may exert a substantial influence on actions requiring a stockholder
vote, potentially in a manner that you do not support.
Our
initial stockholders, including our co-sponsors (and/or their designees) collectively will own 20% of our issued and outstanding
shares of common stock. Accordingly, they may exert a substantial influence on actions requiring a stockholder vote, potentially in a
manner that you do not support, including amendments to our certificate of incorporation. If our initial stockholders, including our
co-sponsors (and/or their designees) purchase any additional shares of common stock in the aftermarket or in privately negotiated
transactions, this would increase their control.
The
grant of registration rights to our initial stockholders may make it more difficult to complete our initial business combination, and
the future exercise of such rights may adversely affect the market price of our shares of common stock.
Pursuant
to a registration and stockholder rights agreement, our initial stockholders, including our co-sponsors and their permitted transferees
can demand that we register the founder shares and the private warrants and the underlying securities. We will bear the cost of registering
these securities. The registration and availability of such a significant number of securities for trading in the public market may have
an adverse effect on the market price of our shares of common stock. In addition, the existence of the registration rights may make our
initial business combination more costly or difficult to conclude. This is because the stockholder of the target business may increase
the equity stake they seek in the combined entity or ask for more cash consideration to offset the negative impact on the market price
of our shares of common stock that is expected when the securities owned by our initial stockholders, including our co-sponsors and
their permitted transferees are registered.
A
provision of our warrant agreement may make it more difficult for us to consummate an initial business combination.
Unlike
most blank check companies, if we issue additional shares of common stock or equity-linked securities for capital raising purposes
in connection with the closing of our initial business combination at a newly issued price of less than $9.20 per share of common stock,
then the exercise price of the warrants will be adjusted to be equal to 115% of higher of the Market Value and the newly issued price
and the $16.50 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 165% of the higher of the Market
Value and the newly issued price. This may make it more difficult for us to consummate an initial business combination with a target
business.
A
market for our securities may not fully develop or be sustained, which would adversely affect the liquidity and price of our securities.
The
price of our securities may vary significantly due to one or more potential business combinations and general market or economic conditions.
An active trading market for our securities may not fully develop or, if developed or be sustained. Additionally, if our securities become
delisted from the NYSE for any reason, and are quoted on the OTC Bulletin Board, an inter-dealer automated quotation system for
equity securities not listed on a national exchange, the liquidity and price of our securities may be more limited than if we were listed
on the NYSE or another national exchange. You may be unable to sell your securities unless a market can be fully developed and sustained.
Our
securities may not continue to be listed on the NYSE in the future, which could limit investors’ ability to make transactions in
our securities and subject us to additional trading restrictions.
Our
securities are currently listed on the NYSE. However, we cannot assure you that our securities will continue to be listed on the NYSE
in the future. Additionally, in connection with our business combination, the NYSE may require us to file a new initial listing application
and meet its initial listing requirements as opposed to its more lenient continued listing requirements. We cannot assure you that we
will be able to meet those initial listing requirements at that time. If the NYSE delists our securities from trading on its exchange,
we could face significant material adverse consequences, including:
|
● |
a limited availability
of market quotations for our securities; |
|
● |
a reduced liquidity with
respect to our securities; |
|
● |
a determination that our
shares of common stock are a “penny stock,” which will require brokers trading in our shares of common stock to adhere
to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for our shares
of common stock; |
|
● |
a limited amount of news
and analyst coverage for our company; and |
|
● |
a decreased ability to
issue additional securities or obtain additional financing in the future. |
Our
certificate of incorporation designates the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain types
of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable
judicial forum for disputes with our company or our company’s directors, officers or other employees.
Our
certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery
of the State of Delaware shall, to the fullest extent permitted by law, be the sole and exclusive forum for any (1) derivative action
or proceeding brought on behalf of our company, (2) action asserting a claim of breach of a fiduciary duty owed by any director,
officer, employee or agent of our company to our company or our stockholders, or any claim for aiding and abetting any such alleged breach,
(3) action asserting a claim against our company or any director or officer of our company arising pursuant to any provision of
the DGCL or our certificate of incorporation or our bylaws, or (4) action asserting a claim against us or any director or officer
of our company governed by the internal affairs doctrine except for, as to each of (1) through (4) above, any claim (a) as
to which the Court of Chancery determines that there is an indispensable party not subject to the jurisdiction of the Court of Chancery
(and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination),
(b) which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery, or (c) arising under
the federal securities laws, including the Securities Act, as to which the Court of Chancery and the federal district court for the District
of Delaware shall concurrently be the sole and exclusive forums. Notwithstanding the foregoing, the inclusion of such provision in our
certificate of incorporation is not be deemed to be a waiver by our stockholders of our obligation to comply with federal securities
laws, rules and regulations, and the provisions of this paragraph in our certificate of incorporation will not apply to suits brought
to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States
of America shall be the sole and exclusive forum. Any person or entity purchasing or otherwise acquiring any interest in any shares of
our capital stock shall be deemed to have notice of and to have consented to the forum provisions in our certificate of incorporation.
If any action the subject matter of which is within the scope the forum provisions is filed in a court other than a court located within
the State of Delaware (a “foreign action”) in the name of any stockholder, such stockholder shall be deemed to have consented
to: (x) the personal jurisdiction of the state and federal courts located within the State of Delaware in connection with any action
brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having service of process
made upon such stockholder in any such enforcement action by service upon such stockholder’s counsel in the foreign action as agent
for such stockholder.
This
choice-of-forum provision may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for
disputes with our company or its directors, officers or other employees, which may discourage such lawsuits. Alternatively, if a court
were to find this provision of our certificate of incorporation inapplicable or unenforceable with respect to one or more of the specified
types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could
materially and adversely affect our business, financial condition and results of operations and result in a diversion of the time and
resources of our management and board of directors.
Our private
warrants and Additional Shares that may be issued pursuant to the Subscription Agreement are accounted for as liabilities and the changes
in value of our private warrants and such Additional Shares could have a material effect on our financial results.
On
April 12, 2021, the staff of the SEC (the “SEC Staff”) issued the SEC Statement, wherein the SEC Staff expressed its view
that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities on the SPAC’s
balance sheet as opposed to being treated as equity. Specifically, the SEC Statement focused on certain settlement terms and provisions
related to certain tender offers following a business combination, which terms are similar to those contained in the warrant agreement
governing our warrants. As a result of the SEC Statement, we reevaluated the accounting treatment of our warrants, and pursuant to the
guidance in ASC 815, Derivatives and Hedging (“ASC 815”), determined the private warrants should be classified as derivative
liabilities measured at fair value on our balance sheet, with any changes in fair value to be reported each period in earnings on our
statement of operations.
In addition, as more fully
described in Note 6 to the restated financial statements, pursuant to the Subscription Agreements, Additional Shares may be issued to
certain investors based on terms and conditions set forth in the Subscription Agreements. As a result, the Subscription Agreements create
a potential obligation to issue Additional Shares and, therefore, we should have classified this instrument to issue Additional Shares
as a derivative liability in the Original Filing. Under this accounting treatment, we are required to measure the fair value of the PIPE
derivative liability (as defined in the restated financial statements) on the date of issuance, and at the end of each reporting period
and recognize any change in fair value in our operating results for the current period.
As
a result of the recurring fair value measurements, our financial statements may fluctuate quarterly, based on factors which are outside
of our control. Due to the recurring fair value measurement, we expect that we will recognize non-cash gains or losses on our warrants
and our PIPE derivative liability each reporting period and that the amount of such gains or losses could be material.
We
have identified material weaknesses in our internal control over financial reporting. If we are unable to develop and maintain an effective
system of internal control over financial reporting, we may not be able to accurately report our financial results in a timely manner,
which may adversely affect investor confidence in us and materially and adversely affect our business and operating results.
In
connection with the Restatement described in this Amendment, our management reassessed the effectiveness of our disclosure controls and
procedures for the periods affected by the Restatement. As a result of that reassessment, our management determined that our disclosure
controls and procedures were not effective as of December 31, 2021 due to the material weaknesses with respect to compiling information
to prepare our financial statements in accordance with U.S. GAAP. The material weaknesses are due to the previously omitted subsequent
event disclosure of an advance from Quantum Ventures, the analysis and full disclosure of the Merger Agreement, the impact of the Merger
Agreement on our going concern assessment and the impact of the Merger Agreement as it relates to the classification of our complex accounting
instruments, as well as the related determination of the fair value of the PIPE derivative liability, accumulated deficit, net loss and
related financial disclosures.
Previously,
in connection with our initial public offering, we accounted for a portion of the proceeds received from the offering as stockholders’
equity. Following the SEC’s guidance on this issue, management identified errors in its historical financial statements and performed
a quantitative assessment under SAB 99. Based on this assessment, after consultation with our independent registered public accounting
firm, our management and audit committee concluded that a restatement of our financial statements for periods prior to September 30,
2021 was required to reclassify such amounts as common stock subject to possible redemption and that a material weakness in our internal
controls over financial reporting exists as a result of the identified errors that led to such restatement.
Previously,
following the issuance of the SEC Statement described above, after consultation with our independent registered public accounting firm,
our management and our audit committee concluded that, in light of the SEC Statement, we identified a material weakness in our internal
control over financial reporting. In addition, in connection with the restatement of our financial statements as of and for the three
months ended March 31, 2021, management and our audit committee concluded that a material weakness also exists as it relates to the accounting
for our public warrants.
A
material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is
a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented, or detected
and corrected on a timely basis.
Effective
internal controls are necessary for us to provide reliable financial reports and prevent fraud. We continue to evaluate steps to remediate
the material weakness. These remediation measures may be time consuming and costly and there is no assurance that these initiatives will
ultimately have the intended effects.
If
we identify any new material weaknesses in the future, any such newly identified material weakness could limit our ability to prevent
or detect a misstatement of our accounts or disclosures that could result in a material misstatement of our annual or interim financial
statements. In such case, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic
reports in addition to applicable stock exchange listing requirements, investors may lose confidence in our financial reporting and our
stock price may decline as a result. We cannot assure you that the measures we have taken to date, or any measures we may take in the
future, will be sufficient to avoid potential future material weaknesses.
We,
and following our initial business combination, the post-business combination company, may face litigation and other risks as a result
of the material weaknesses in our internal control over financial reporting.
As
a result of the material weaknesses in our internal controls over financial reporting described above, the change in accounting for the
private warrants, the change in classification of redeemable public shares, the reclassification of Additional Shares issuable pursuant
to the Subscription Agreement as a derivative liability, the change in our going concern assessment, the restatements and other matters
raised or that may in the future be raised by the SEC, we face potential for litigation or other disputes which may include, among others,
claims invoking the federal and state securities laws, contractual claims or other claims arising from the material weaknesses in our
internal control over financial reporting and the preparation of our financial statements. As of the date of this Annual Report, we have
no knowledge of any such litigation or dispute. However, we can provide no assurance that such litigation or dispute will not arise in
the future. Any such litigation or dispute, whether successful or not, could have a material adverse effect on our business, results
of operations and financial condition or our ability to complete a business combination.
RISKS
RELATING TO ACQUIRING AND OPERATING A BUSINESS OUTSIDE OF THE UNITED STATES
We
may effect our initial business combination with a company located outside of the United States.
If
we effect our initial business combination with a company located outside of the United States, we would be subject to any special
considerations or risks associated with companies operating in the target business’ home jurisdiction, including any of the following:
|
● |
rules and regulations or
currency redemption or corporate withholding taxes on individuals; |
|
● |
laws governing the manner
in which future business combinations may be effected; |
|
● |
exchange listing and/or
delisting requirements; |
|
● |
tariffs and trade barriers; |
|
● |
regulations related to
customs and import/export matters; |
|
● |
tax issues, such as tax
law changes and variations in tax laws as compared to the United States; |
|
● |
currency fluctuations and
exchange controls; |
|
● |
challenges in collecting
accounts receivable; |
|
● |
cultural and language differences; |
|
● |
employment regulations; |
|
● |
crime, strikes, riots, civil disturbances, terrorist attacks and wars,
including the conflict in Ukraine and the surrounding region; and |
|
● |
deterioration of political
relations with the United States. We may not be able to adequately address these additional risks. If we were unable to do so,
our operations might suffer. |
There
are costs and difficulties inherent in managing cross-border business operations.
Managing
a business, operations, personnel or assets in another country is challenging and costly. Any management that we may have (whether based
abroad or in the United States) may be inexperienced in cross-border business practices and unaware of significant differences
in accounting rules, legal regimes and labor practices. Even with a seasoned and experienced management team, the costs and difficulties
inherent in managing cross-border business operations, personnel and assets can be significant (and much higher than in a purely
domestic business) and may negatively impact our financial and operational performance.
Social
unrest, acts of terrorism, regime changes, changes in laws and regulations, political upheaval, or policy changes or enactments may occur
in a country in which we may operate after we effect our initial business combination.
Political
events in another country may significantly affect our business, assets or operations. Social unrest, acts of terrorism, regime changes,
changes in laws and regulations, political upheaval, and policy changes or enactments could negatively impact our business in a particular
country.
Many
countries have difficult and unpredictable legal systems and underdeveloped laws and regulations that are unclear and subject to corruption
and inexperience.
Our
ability to seek and enforce legal protections, including with respect to intellectual property and other property rights, or to defend
ourselves with regard to legal actions taken against us in a given country, may be difficult or impossible, which could adversely impact
our operations, assets or financial condition.
Rules
and regulations in many countries are often ambiguous or open to differing interpretation by responsible individuals and agencies at
the municipal, state, regional and federal levels. The attitudes and actions of such individuals and agencies are often difficult to
predict and inconsistent.
Delay
with respect to the enforcement of particular rules and regulations, including those relating to customs, tax, environmental and labor,
could cause serious disruption to operations abroad and negatively impact our results.
If
relations between the United States and foreign governments deteriorate, it could cause potential target businesses or their goods
and services to become less attractive.
The
relationship between the United States and foreign governments could be subject to sudden fluctuation and periodic tension. For
instance, the United States may announce its intention to impose quotas on certain imports or become involved in trade wars with
other nations. Such import quotas or trade wars may adversely affect political relations between the two countries and result in retaliatory
countermeasures by the foreign government in industries that may affect our ultimate target business. Changes in political conditions
in foreign countries and changes in the state of U.S. relations with such countries are difficult to predict and could adversely affect
our operations or cause potential target businesses or their goods and services to become less attractive. Because we are not limited
to any specific industry, there is no basis for investors to evaluate the possible extent of any impact on our ultimate operations if
relations are strained between the United States and a foreign country in which we acquire a target business or move our principal
manufacturing or service operations.
If
our management following our initial business combination is unfamiliar with United States securities laws, they may have to expend
time and resources becoming familiar with such laws.
Following
our initial business combination, our management may resign from their positions as officers or directors of the company and the management
of the target business at the time of the business combination will remain in place. Management of the target business may not be familiar
with United States securities laws. If new management is unfamiliar with our laws, they may have to expend time and resources becoming
familiar with such laws. This could be expensive and time-consuming, and could lead to various regulatory issues, which may adversely
affect our operations.
Currency
policies may cause a target business’ ability to succeed in the international markets to be diminished.
In
the event we acquire a non-U.S. target all revenues and income would likely be received in a foreign currency and the dollar equivalent
of our net assets and distributions, if any, could be adversely affected by reductions in the value of the local currency. The value
of the currencies in our target regions fluctuate and are affected by, among other things, changes in political and economic conditions.
Any change in the relative value of such currency against our reporting currency may affect the attractiveness of any target business
or, following consummation of our initial business combination, our financial condition and results of operations. Additionally, if a
currency appreciates in value against the dollar prior to the consummation of our initial business combination, the cost of a target
business as measured in dollars will increase, which may make it less likely that we are able to consummate such transaction.
Because
foreign law could govern our material agreements, we may not be able to enforce our rights within such jurisdiction or elsewhere.
Foreign
law could govern our material agreements. The target business may not be able to enforce any of its material agreements or remedies may
not be available outside of such foreign jurisdiction’s legal system. The system of laws and the enforcement of existing laws and
contracts in such jurisdiction may not be as certain in implementation and interpretation as in the United States. The judiciaries
in certain foreign countries may be relatively inexperienced in enforcing corporate and commercial law, leading to a higher than usual
degree of uncertainty as to the outcome of any litigation, any such jurisdictions may not favor outsiders or could be corrupt. As a result,
the inability to enforce or obtain a remedy under any of our future agreements could result in a significant loss of business and business
opportunities.
RISKS
RELATING TO TAXATION
Our
initial business combination and our structure thereafter may not be tax-efficient to our stockholders and warrant holders. As a result
of our initial business combination, our tax obligations may be more complex, burdensome and uncertain.
Although
we will attempt to structure our initial business combination in a tax-efficient manner, tax structuring considerations are complex,
the relevant facts and law are uncertain and may change, and we may prioritize commercial and other considerations over tax considerations.
For example, in connection with our initial business combination and subject to requisite stockholder approval, we may structure our
business combination in a manner that requires stockholders and/or warrant holders to recognize gain or income for tax purposes. We do
not intend to make any cash distributions to stockholders or warrant holders to pay taxes in connection with our business combination
or thereafter. Accordingly, a stockholder or a warrant holder may need to satisfy any liability resulting from our initial business combination
with cash from its own funds or by selling all or a portion of such holder’s shares or warrants. In addition, we may effect a business
combination with a target company in another jurisdiction or reincorporate in a different jurisdiction (including, but not limited to,
the jurisdiction in which the target company or business is located). As a result, stockholders and warrant holders may be subject to
additional income, withholding or other taxes with respect to their ownership of us after our initial business combination.
Furthermore, we may effect
a business combination with a target company that has business operations outside of the United States, and, possibly, business operations
in multiple jurisdictions. If we effect such a business combination, we could be subject to significant income, withholding and other
tax obligations in a number of jurisdictions with respect to income, operations and subsidiaries related to those jurisdictions. Due to
the complexity of tax obligations and filings in other jurisdictions, we may have a heightened risk related to audits or examinations
by taxing authorities. This additional complexity and risk could have an adverse effect on our after-tax profitability and financial
condition.
An investment in our securities may result
in uncertain or adverse U.S. federal income tax consequences.
The U.S. federal income tax
consequences of a cashless exercise of warrants is unclear under current law. In addition, it is unclear whether the redemption rights
with respect to our shares of common stock suspend the running of a U.S. Holder’s holding period for purposes of determining whether
any gain or loss realized by such holder on the sale or exchange of common stock is long-term capital gain or loss and for determining
whether any dividend we pay would be considered “qualified dividend income” for U.S. federal income tax purposes.
We would be subject to a second level of
U.S. federal income tax on a portion of our income if we are determined to be a personal holding company (a “PHC”) for U.S.
federal income tax purposes.
We could be subject to a second
level of U.S. federal income tax on a portion of our income if we are determined to be a personal holding company, or PHC, for U.S. federal
income tax purposes. A U.S. corporation generally will be classified as a PHC for U.S. federal income tax purposes in a given taxable
year if (i) at any time during the last half of such taxable year, five or fewer individuals (without regard to their citizenship
or residency and including as individuals for this purpose certain entities such as certain tax-exempt organizations, pension funds
and charitable trusts) own or are deemed to own (pursuant to certain constructive ownership rules) more than 50% of the stock of the corporation
by value and (ii) at least 60% of the corporation’s adjusted ordinary gross income, as determined for U.S. federal income tax
purposes, for such taxable year consists of PHC income (which includes, among other things, dividends, interest, certain royalties, annuities
and, under certain circumstances, rents).
Depending on the date and
size of our initial business combination, it is possible that at least 60% of our adjusted ordinary gross income may consist of PHC income.
In addition, depending on the concentration of our stock in the hands of individuals, including the members of our initial stockholders
and certain tax-exempt organizations, pension funds and charitable trusts, it is possible that more than 50% of our stock may be
owned or deemed owned (pursuant to the constructive ownership rules) by such persons during the last half of a taxable year. Thus, no
assurance can be given that we will not be a PHC in the future. If we are or were to become a PHC in a given taxable year, we would be
subject to an additional PHC tax, currently 20%, on our undistributed PHC income, which generally includes our taxable income, subject
to certain adjustments.
ITEM 1B. UNRESOLVED STAFF COMMENTS
None.
ITEM 2. PROPERTIES
We currently maintain our
executive offices at 4221 W. Boy Scout Blvd., Suite 300, Tampa, FL 33607. We consider our current office space adequate for our current
operations.
ITEM 3. LEGAL PROCEEDINGS
There is no material litigation,
arbitration or governmental proceeding currently pending against us or any members of our management team.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS
OPERATIONS
Quantum FinTech Acquisition Corporation (the “Company”)
was incorporated in Delaware on October 1, 2020. The Company is a blank check company formed for the purpose of entering into a merger,
share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or
more businesses or entities (the “Business Combination”). The Company is an early stage and emerging growth company and, as
such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
On November 4, 2021, the Company entered into a Merger Agreement by and among the Company, TradeStation, and Merger Sub. The Merger Agreement,
and other parties thereto, are described in Note 6.
As of December 31, 2021, the Company had not commenced
any operations. All activity through December 31, 2021 relates to the Company’s formation, the initial public offering (“Initial
Public Offering”), which is described below, and identifying a target company for a Business Combination. The Company will not generate
any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating
income and expenses in the form of interest income from the proceeds derived from the Initial Public Offering and change in fair value
of warrant liability.
The registration statements for the Company’s
Initial Public Offering were declared effective on February 4, 2021. On February 9, 2021, the Company consummated the Initial Public Offering
of 17,500,000 units (the “Units” and, with respect to the shares of common stock included in the Units sold, the “Public
Shares”), at $10.00 per Unit, generating gross proceeds of $175,000,000, which is described in Note 3.
Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of 5,562,500 warrants (each, a “Private Warrant” and, collectively, the
“Private Warrants”) at a price of $1.00 per Private Warrant in a private placement to Quantum Ventures LLC (“Quantum
Ventures”), who purchased 4,450,000 Private Warrants and Chardan Quantum LLC (“Chardan Quantum” and together with Quantum
Ventures, the “Co-Sponsors”) who purchased 1,112,500 Private Warrants, generating gross proceeds of $5,562,500, which is described
in Note 4.
Following the closing of the Initial Public Offering
on February 9, 2021, an amount of $175,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public
Offering and the sale of the Private Warrants was placed in a trust account (the “Trust Account”), invested in U.S. government
treasury bills, notes or bonds having a maturity of 185 days or less and/or (ii) in money market funds meeting certain conditions under
Rule 2a-7 of the Investment Company Act of 1940, as amended (the “Investment Company Act”), as determined by the Company,
until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the
Company’s stockholders, as described below.
On February 12, 2021, the underwriters fully exercised
their over-allotment option, resulting in an additional 2,625,000 Units issued for an aggregate amount of $26,250,000. In connection with
the underwriters’ full exercise of their over-allotment option, the Company also consummated the sale of an additional 590,625 Private
Warrants at $1.00 per Private Warrant, generating total proceeds of $590,625. A total of $26,250,000 was deposited into the Trust Account,
bringing the aggregate proceeds held in the Trust Account to $201,250,000.
Transaction costs amounted to $5,017,526, consisting
of $4,528,125 of underwriting fees, and $489,401 of other offering costs. Offering costs amounting to $5,008,178 were charged to stockholders’
equity upon the completion of the Initial Public Offering, and $9,348 of the offering costs were related to the warrant liability and
charged to the operating and formation costs in the statement of operations.
The Company’s management has broad discretion
with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Warrants, although
substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must
complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined
below) (excluding the taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business
Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more
of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to
be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able
to complete a Business Combination successfully.
QUANTUM
FINTECH ACQUISITION CORPORATION
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
The Company will provide its stockholders with
the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection
with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the
Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its
discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust
Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account
and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business
Combination with respect to the Company’s warrants.
The Company will proceed with a Business Combination
if the Company has net tangible assets of at least $5,000,001 immediately prior to or upon such consummation of a Business Combination
and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder
vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company
will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”),
conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file
tender offer documents with the SEC containing substantially the same information as would be included in a proxy statement prior to completing
a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder
approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the
proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination,
the Co-Sponsors have agreed to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering (a)
in favor of approving a Business Combination and (b) not to redeem any shares in connection with a stockholder vote to approve a Business
Combination or sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder
may elect to redeem their Public Shares, without voting, if they do vote, irrespective of whether they vote for or against the proposed
Business Combination.
At the time of the Initial Public Offering, the
Co-Sponsors and the other holders of the Company’s shares prior to the Initial Public Offering (the “initial stockholders”)
agreed (A) to vote their Founder Shares and any Public Shares in favor of a Business Combination, (B) not to propose, or vote in favor
of, prior to and unrelated to a Business Combination, an amendment to the Company’s Amended and Restated Certificate of Incorporation
that would affect the substance or timing of the Company’s redemption obligation to redeem all Public Shares if the Company cannot
complete a Business Combination within 18 months (August 9, 2022) (or 24 months from the closing of the Initial Public Offering (February
9, 2023) if the Company has executed a letter of intent, agreement in principle or definitive agreement for a Business Combination by
August 9, 2022) unless the Company provides public stockholders an opportunity to redeem their Public Shares in conjunction with any such
amendment, (C) not to convert any shares (including the Founder Shares) into the right to receive cash from the Trust Account in connection
with a stockholder vote to approve the Company’s Business Combination or sell any shares to the Company in a tender offer in connection
with a Business Combination, and (D) that the Founder Shares shall not participate in any liquidating distribution upon winding up if
a Business Combination is not consummated. As a result of the Company entering into a Merger Agreement on November 4, 2021, the Company has until February
9, 2023 to complete Business Combination.
The Company has until August 9, 2022 (or February
9, 2023, as applicable) to complete a Business Combination (the “Combination Period”). If the Company is unable to complete
a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up,
(ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price,
payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the
Trust Account and not previously released to the Company to pay taxes, dissolution expenses up to $100,000, divided by the number of then
outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the
right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following
such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve
and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements
of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants,
which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.
QUANTUM
FINTECH ACQUISITION CORPORATION
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
At the time of the Initial Public Offering, the
initial stockholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business
Combination within the Combination Period. However, if the initial stockholders acquire Public Shares in or after the Initial Public Offering,
such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination
within the Combination Period. In the event of such distribution, it is possible that the per share value of the assets remaining available
for distribution will be less than the Initial Public Offering price per Unit ($10.00).
In order to protect the amounts held in the Trust
Account, Quantum Ventures has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered
or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement,
reduce the amount of funds in the Trust Account to below $10.00 per Public Share, except as to any claims by a third party who executed
a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any
monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of Initial Public
Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).
Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the insiders will not be responsible
to the extent of any liability for such third-party claims. The Company has sought and will continue to seek to reduce the possibility
that the insiders will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers
(except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which
the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies
held in the Trust Account.
Going Concern (Restated)
As of December 31, 2021, the Company had $63,179
in its operating bank accounts, $201,308,628 in marketable securities held in the Trust Account to be used for a Business Combination
or to repurchase or redeem stock in connection therewith and a working capital deficit of $6,805,902. The working capital deficit includes
$4,566,000 of a PIPE derivative liability which will be settled at the closing of the Business Combination. As of December 31, 2021,
$58,628 of the amount on deposit in the Trust Account represented interest income and unrealized losses on marketable securities, which
is available to the Company for working capital needs. Through December 31, 2021, the Company had not withdrawn any amounts from the
Trust Account for such needs.
In October 2021, Quantum Ventures committed to
provide the Company an aggregate of $2,000,000 in loans in connection with the Working Capital Loans as described in Note 5. The Company
may raise additional capital through loans or additional investments from Quantum Ventures or its stockholders, officers, directors, or
third parties. The Company’s officers and directors and the Sponsors may, but are not obligated to (except as described above),
loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s
working capital needs. The Company has not drawn on the Working Capital Loans as of December 31, 2021. In February 2022, Quantum Ventures
committed to provide the Company an additional $1,000,000 for a total of $3,000,000 in loans in connection with the Working Capital Loans
as described in Note 5. Pursuant to the Merger Agreement, the Company needs approval from TradeStation (as defined in Note 6) to borrow
amounts over $500,000.
In connection with the Company’s assessment
of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Codification Subtopic
205-40, “Presentation of Financial Statements – Going Concern,” the liquidity and date for mandatory liquidation
and dissolution raises substantial doubt about the Company’s ability to continue as a going concern through February 9, 2023 (the
scheduled liquidation date of the Company if it does not complete a Business Combination prior to such date). Management’s plan
is to complete a business combination prior to February 9, 2023. The Company entered into a definitive Merger Agreement on November 4,
2021 (as defined below in Note 6) and is in the process of completing this Business Combination. Management has assessed the likelihood
of whether it will be able to carry out its plan to complete this business combination prior to February 9, 2023. Management believes
the business combination will occur prior to the termination set forth in the Merger Agreement of August 1, 2022 (270 days following
the date of the Merger Agreement), which is before the mandatory liquidation date. On March 14, 2022, the Company issued an unsecured
non-interest bearing promissory note, effective as of January 3, 2022, in the amount of up to $480,000 to Quantum Ventures to evidence
the Working Capital Loans. Pursuant to the Merger Agreement, the Company needs approval from TradeStation to borrow amounts over $500,000,
so the Company may not be able to utilize the Working Capital Loan commitments or obtain additional financing. If the Company is unable
to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily
be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company
cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions
raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the date that the
financial statements are issued. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be
required to liquidate after February 9, 2023.
Risks and Uncertainties
Management continues to evaluate the impact of
the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s
financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of
the date of the financial statements. These financial statements do not include any adjustments that might result from the outcome of
this uncertainty.
QUANTUM
FINTECH ACQUISITION CORPORATION
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying financial statements are presented
in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and
regulations of the SEC.
Emerging Growth Company
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting
firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but
any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that
when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging
growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth
company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.
Use of Estimates
The preparation of the financial statements in
conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets
and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.
Making estimates requires management to
exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set
of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate,
could change in the near term due to one or more future confirming events. Two of the more significant accounting estimates included
in these financial statements is the determination of the fair value of the private warrant liabilities and fair value of the sale
of the Founder Shares. Such estimates may be subject to change as more current information becomes available and accordingly the
actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents
as of December 31, 2021 and 2020.
Marketable Securities Held in Trust Account
At December 31, 2021, substantially all of the
assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. All of the
Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance
sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held
in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations.
The estimated fair values of investments held in Trust Account are determined using available market information.
QUANTUM
FINTECH ACQUISITION CORPORATION
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
Offering Costs
Offering costs consisted of legal, and other
expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were
allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis,
compared to total proceeds received. Offering costs allocated to private warrant liabilities were expensed as incurred in the
statements of operations. Offering costs associated with the common stock issued were initially charged to temporary equity and then
accreted to common stock subject to redemption upon the completion of the Initial Public Offering. Offering costs amounting to
$5,008,178 were charged to stockholders’ equity upon the completion of the Initial Public Offering, and $9,348 of the offering
costs were related to the warrant liability and charged to the operating and formation costs in the statement of operations.
Warrant Liabilities
The Company accounts for warrants as either equity-classified
or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance
in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing
Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers
whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480,
and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed
to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of
professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants
are outstanding.
For issued or modified warrants that meet all
of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the
time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required
to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair
value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The fair value of the private warrants
was estimated using a Binomial lattice model approach (see Note 10).
Common Stock Subject to Possible Redemption
The Company accounts for its common stock
subject to possible redemption in accordance with the guidance in ASC 480. Common stock subject to mandatory redemption is
classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including Common stock
that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of
uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock
is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered
to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, all common stock
subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity
(deficit) section of the Company’s balance sheets.
The Company recognizes changes in redemption value
immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting
period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption
amount value. The change in the carrying value of redeemable common stock resulted in charges against additional paid-in capital, to the extent available, and accumulated
deficit.
QUANTUM
FINTECH ACQUISITION CORPORATION
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
At December 31, 2021, the common stock subject
to possible redemption reflected in the balance sheet is reconciled in the following table:
Gross proceeds | |
$ | 201,250,000 | |
Less: | |
| | |
Proceeds allocated to Public Warrants | |
$ | (6,138,125 | ) |
Common stock issuance costs | |
| (5,008,178 | ) |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
$ | 11,146,303 | |
| |
| | |
Common stock subject to possible redemption | |
$ | 201,250,000 | |
Income Taxes
The Company follows the asset and liability method
of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated
future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities
and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and
liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are
established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC 740 prescribes a recognition threshold and
a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax
return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized
tax benefits and no amounts accrued for interest and penalties as of December 31, 2021 and 2020. The Company is currently not aware of
any issues under review that could result in significant payments, accruals or material deviation from its position.
Net Loss per Common Share (Restated)
The Company complies with accounting and
disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net loss per share of common stock is computed by
dividing net loss by the weighted average number of shares of common stock outstanding for the period. Losses are allocated between redeemable and non-redeemable shares based on relative amounts of weighted average
shares outstanding. Accretion associated with the
redeemable shares of common stock is excluded from loss per share as the redemption value approximates fair value.
The calculation of diluted loss per share does
not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since
the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 16,215,625 shares
of common stock in the aggregate. As of December 31, 2021 and 2020, the Company did not have any dilutive securities or other contracts
that could, potentially, be exercised or converted into common stocks and then share in the earnings of the Company. As a result, diluted
net loss per common stock is the same as basic net loss per common stock for the periods presented.
The following table reflects the calculation of
basic and diluted net loss per share of common stock (in dollars, except share amounts):
| |
Year Ended | | |
For the Period from October 1, 2020 (Inception) through | |
| |
December 31, 2021 | | |
December 31, 2020 | |
| |
Redeemable | | |
Non-redeemable | | |
Redeemable | | |
Non-redeemable | |
Basic and diluted net loss per share of common stock | |
| | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| | |
| |
Allocation of net loss | |
$ | (4,465,461 | ) | |
$ | (1,237,332 | ) | |
$ | - | | |
$ | (5,420 | ) |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average shares outstanding | |
| 17,897,945 | | |
| 4,959,332 | | |
| - | | |
| 4,375,000 | |
Basic and diluted net loss per share of common stock | |
$ | (0.25 | ) | |
$ | (0.25 | ) | |
$ | - | | |
$ | (0.00 | ) |
QUANTUM
FINTECH ACQUISITION CORPORATION
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
Concentration of Credit Risk
Financial instruments that potentially subject
the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal
Deposit Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is
not exposed to significant risks on such accounts.
Fair Value of Financial Instruments
The fair value of the Company’s assets and
liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying
amounts represented in the accompanying balance sheets, primarily due to their short-term nature, except for warrant liabilities (see
Note 10).
Derivative Financial Instruments (Restated)
The Company evaluates its financial instruments
to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815. For derivative financial instruments that are accounted for as liabilities, the derivative
instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the
fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments
should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified
in the balance sheet as current or non-current based on whether net-cash settlement or conversion of the instrument could be required
within 12 months of the balance sheet date.
The PIPE Derivative is comprised of the Additional
Shares (as defined in Note 6). The PIPE Derivative meets the criteria for derivative liability classification. As such, the PIPE derivative
liability is recorded at its initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated
fair value of the derivative liability is recognized as a non-cash gain or loss on the statements of operations. The fair value of the
derivative liability is discussed in Note 10.
Recent Accounting Standards
In August 2020, the FASB issued ASU No.
2020-06, “Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in
Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own
Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation
models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to
qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU
2020-06 is effective for the Company for fiscal years beginning after December 15, 2023, including interim periods within those
fiscal years, with early adoption permitted. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on
its financial position, results of operations or cash flows.
Management does not believe that any other
recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the
Company’s financial statements.
NOTE 3. PUBLIC OFFERING
Pursuant to the Initial Public Offering, the Company
sold 20,125,000 Units, inclusive of 2,625,000 Units sold to the underwriters on February 12, 2021 upon the underwriters’ election
to fully exercise their over-allotment option, at a purchase price of $10.00 per Unit. Each Unit will consist of one share of common stock
and one redeemable warrant (“Public Warrant”). Each Public Warrant will entitle the holder to purchase one-half share of common
stock at an exercise price of $11.50 per share (see Note 8).
NOTE 4. PRIVATE PLACEMENT
Simultaneously with the closing of the Initial
Public Offering, Quantum Ventures purchased 4,450,000 Private Warrants and Chardan Quantum purchased 1,112,500 Private Warrants, in each
case, at a price of $1.00 per Private Warrant, for an aggregate purchase price of $5,562,500, in a private placement. On February 12,
2021, in connection with the underwriters’ election to fully exercise their over-allotment option, the Company sold an additional
590,625 Private Warrants to the Co-Sponsors, at a price of $1.00 per Private Warrant, generating gross proceeds of $590,625. Each Private
Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per full share, subject to adjustment (see Note
8). The proceeds from the Private Warrants were added to the proceeds from the Initial Public Offering to be held in the Trust Account.
If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Warrants
will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).
QUANTUM
FINTECH ACQUISITION CORPORATION
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On October 23, 2020, Quantum Ventures purchased
4,312,500 shares (the “Founder Shares”) of the Company’s common stock for an aggregate price of $25,000. In January
2021, Quantum Ventures sold 813,500 Founder Shares to Chardan Quantum and 35,000 Founder Shares to each of the Company’s directors
and director nominees, in each case at the original price per share, resulting in Quantum Ventures holding a balance of 3,254,000 Founder
Shares. On February 4, 2021, the Company effected a stock dividend of 718,750 shares with respect to its common stock, resulting in the
initial stockholders holding an aggregate of 5,031,250 Founder Shares. The Founder Shares included an aggregate of up to 656,250 shares
that were subject to forfeiture. As a result of the underwriters’ election to fully exercise their over-allotment option on February
12, 2021, no Founder Shares are currently subject to forfeiture.
At the time of the Initial Public Offering, the
initial stockholders agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until (1)
with respect to 50% of the Founder Shares, the earlier of nine months after the completion of a Business Combination and the date on which
the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after a Business Combination and (2)
with respect to the remaining 50% of the Founder Shares, nine months after the completion of a Business Combination, or earlier, in either
case, if, subsequent to a Business Combination, the Company completes a liquidation, merger, stock exchange or other similar transaction
which results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities
or other property. If the Company seeks stockholder approval in connection with a Business Combination, the Co-Sponsors have agreed to
vote its their Founder Shares and any Public Shares purchased during or after the Initial Public Offering (a) in favor of approving a
Business Combination and (b) not to redeem any shares in connection with a stockholder vote to approve a Business Combination or sell
any shares to the Company in a tender offer in connection with a Business Combination.
The sale of the Founders Shares to the Company’s
directors and director nominees is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”).
Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The fair
value of the 245,000 shares granted to the Company’s directors and director nominees was $1,462,650 or $5.97 per share. The Founders
Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related
to the Founders Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature
in this circumstance. As of December 31, 2021, the Company determined that a Business Combination is not considered probable, and, therefore,
no stock-based compensation expense has been recognized. Stock-based compensation would be recognized at the date a Business Combination
is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founders Shares times the
grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares.
Administrative Services Agreement
The Company agreed, commencing on February 4,
2021, to pay Quantum Ventures a total of $10,000 per month for office space, utilities and secretarial support. Upon completion of the
Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the year ended December
31, 2021, the Company incurred and paid $110,000 in fees for these services, which are included in the operating and formation costs in
the accompanying statements of operations. For the period from October 1, 2020 (inception) through December 31, 2020, the Company did
not incur any fees for these services.
QUANTUM
FINTECH ACQUISITION CORPORATION
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
Promissory Note – Related Party
On October 1, 2020, the Company issued an unsecured
promissory note to Quantum Ventures (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal
amount of $200,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) January 31, 2021 and (ii) the completion
of the Initial Public Offering. As of December 31, 2021 and 2020, there was no balance and $130,100, respectively, outstanding under the
Promissory Note. The outstanding amount of $154,057 was repaid at the closing of the Initial Public Offering on February 9, 2021.
Related Party Loans (Restated)
In order to finance transaction costs in connection
with a Business Combination, Quantum Ventures or an affiliate of Quantum Ventures, or certain of the Company’s officers and directors
may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans
would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the
lender’s discretion, up to $1,500,000 of notes may be converted upon completion of a Business Combination into warrants at a price
of $1.00 per warrant. Such warrants would be identical to the Private Warrants. In the event that a Business Combination does not close,
the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the
Trust Account would be used to repay the Working Capital Loans.
In October 2021, Quantum Ventures committed to
provide the Company an aggregate of $2,000,000 in loans in connection with the Working Capital Loans. In February 2022, Quantum Ventures
committed to provide the Company an additional $1,000,000 for a total of $3,000,000 in loans in connection with the Working Capital Loans.
The Company needs approval from TradeStation (as defined in Note 6) to borrow amounts over $500,000. Through the date of this filing,
the Company has borrowed $242,101 under a promissory note evidencing the Working Capital Loans that provided for borrowings up to $480,000.
The outstanding amount under such promissory note is required to be repaid in connection with the Closing.
NOTE 6. COMMITMENTS AND CONTINGENCIES
Registration Rights
Pursuant to a registration rights agreement
entered into on February 4, 2021, the holders of the Founder Shares, as well as the holders of the Private Warrants (and underlying
securities) and any warrants issued in payment of Working Capital Loans made to the Company (and underlying securities) will have
registration and stockholder rights pursuant to an agreement to be signed prior to or on the effective date of the Initial Public
Offering. The holders of a majority of these securities are entitled to make up to two demands that the Company register such
securities. The holders of the majority of the insider shares can elect to exercise these registration rights at any time commencing
three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of
the Private Warrants (and underlying securities) can elect to exercise these registration rights at any time after the consummation
of a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to
registration statements filed subsequent to the consummation of a Business Combination. The registration and stockholder rights
agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the
Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration
statements.
Underwriting Agreement
The Company granted the underwriters a 45-day
option to purchase up to 2,625,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting
discounts and commissions. On February 12, 2021, the underwriter’s elected to fully exercise the over-allotment option to purchase
an additional 2,625,000 Public Units at a price of $10.00 per Public Unit.
Business Combination Marketing Agreement
The Company engaged the underwriters as advisors
in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business
Combination and the target business’s attributes, introduce the Company to potential investors that are interested in purchasing
the Company’s securities in connection with the potential Business Combination, assist the Company in obtaining stockholder approval
for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination.
The Company will pay the underwriters the marketing fee for such services upon the consummation of our initial business combination in
an amount equal to, in the aggregate, 3.5% of the gross proceeds of the Initial Public offering or $7,043,750.
QUANTUM
FINTECH ACQUISITION CORPORATION
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
Merger Agreement (Restated)
On November 4, 2021, the Company entered
into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, TradeStation Group, Inc., a
Florida corporation (“TradeStation”), and TSG Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of
TradeStation (“Merger Sub”). TradeStation provides a multi-asset trading platform on desktop, web and mobile as a
self-clearing online broker for the equities, options, futures and cryptocurrency self-directed investor markets. The Merger
Agreement was unanimously approved by the Company’s board of directors. If the Merger Agreement is approved by the
Company’s stockholders, and the transactions contemplated by the Merger Agreement are consummated, Merger Sub will merge with
and into the Company (the “Merger”), with the Company continuing as the surviving corporation and a wholly owned
subsidiary of TradeStation (the “TradeStation Business Combination”).
Prior to the closing of the TradeStation Business
Combination (the “Closing”), TradeStation will undergo a pre-closing reorganization which will result in there being 163,898,232
shares of common stock of TradeStation (“TradeStation Common Stock”) issued and outstanding, all held by Monex Group, Inc.
(“Monex”), the sole shareholder of TradeStation. At the Closing, Monex will retain 129,750,000 shares of TradeStation Common
Stock and deliver 34,148,232 shares of TradeStation Common Stock to an escrow agent (the “Monex Earn Out Shares”). The Monex
Earn Out Shares will be released to Monex upon certain milestones (based on the achievement of certain price targets of TradeStation Common
Stock following the Closing). In the event such milestones are not met within five years of the Closing, the Monex Earn Out Shares will
be automatically released to TradeStation for cancellation. In addition, at the Closing, certain Sponsors (as defined below) will deliver
to the escrow agent an aggregate of 798,894 shares of TradeStation Common Stock that such Sponsors would otherwise receive as consideration
in the Merger (the “Sponsor Earn Out Shares,” and together with the Monex Earn Out Shares, the “Earn Out Shares”).
The Sponsor Earn Out Shares will be subject to the same milestones as the Monex Earn Out Shares. In the event such milestones are not
met within five years of the Closing, the Sponsor Earn Out Shares will be automatically released to TradeStation for cancellation.
In
connection with the Closing, (i) each share of the Company’s common stock (“Company Common Stock”) that (x) is held
by Quantum Ventures LLC and Chardan Quantum LLC and the Company’s directors and officers (collectively, the “Sponsors”)
after taking into effect the forfeitures described below or (y) was acquired pursuant to the Subscription Agreements (as further described
below), will be converted into one share of TradeStation Common Stock, (ii) each share of Company Common Stock (other than the shares
referred to in clause (i)) that is outstanding and has not been redeemed will be converted into a number of shares of TradeStation Common
Stock equal to (A) the sum of (1) the number of Public Shares outstanding for which holders have not elected redemption as of immediately
prior to the Closing and (2) 750,000 divided by (B) the number of Public Shares outstanding for which holders have not elected redemption
immediately prior to the Closing.
Each outstanding warrant to purchase Company Common
Stock (“Company Warrant”) will become a warrant to purchase TradeStation Common Stock, with each such warrant exercisable
for the number of shares of TradeStation Common Stock the holder of the Company Warrant would have received in the Merger if it exercised
the Company Warrant immediately prior to the Merger.
On December 17, 2021, the Company entered into
an amendment (the “Amendment”) to the Merger Agreement.
The Amendment caps the exchange ratio for which
Public Shares will be exchanged for shares of TradeStation common stock in the Merger. The parties considered the potentially dilutive
effect of the Company’s warrants arising from the original exchange ratio in scenarios where more than 90% of the Public Shares
are redeemed, and agreed to the addition of the cap to mitigate such potentially dilutive effect. The cap of 1.3727 shares is equivalent
to the exchange ratio in scenarios where 90% of the Public Shares are redeemed.
In connection with the Closing, each Public Share
that is outstanding and has not been redeemed will be converted into a number of shares of TradeStation common stock equal to the lower
of (A) 1.3727 and (B) (1) the sum of (x) the number of Public Shares outstanding for which holders have not elected redemption as of immediately
prior to the close of the Business Combination plus (y) 750,000 divided by (2) the number of public shares outstanding for which holders
have not elected redemption immediately prior to the close of the Business Combination.
In addition, the Amendment revises Exhibit B of
the Original Agreement – the form of the Amended and Restated Charter of TradeStation following the Business Combination –
to remove classes for the post-closing board of directors and to remove the right of Monex to appoint directors to vacancies on the post-closing
board of directors of TradeStation. Following the Closing, each director shall serve for a term expiring at the first annual meeting of
shareholders and shall be elected until the next annual meeting of shareholders and vacancies on the post-closing board of directors shall
be filled by the affirmative vote of a majority of the directors then in office.
QUANTUM
FINTECH ACQUISITION CORPORATION
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
Subscription Agreements (Restated)
Additionally, the Company and TradeStation
entered into subscription agreements (collectively, the “Subscription Agreements”), each dated as of November 4, 2021, with
certain investors (collectively, the “PIPE Investors”) pursuant to which, among other things, the Company agreed to issue
and sell, in private placements to close immediately prior to the Closing, an aggregate of 12,500,000 shares of the Company’s common
stock for $10.00 per share (the “Company PIPE Shares”), including 5,000,000 shares to Monex. The PIPE Investment will be
consummated substantially concurrently with the Closing, subject to the terms and conditions contemplated by the Subscription Agreements.
The Company PIPE Shares will be converted in the Merger into an equal number of shares of TradeStation Common Stock, subject to adjustment
as described below.
Subject to limitations described below, in the
event that the Adjustment Period VWAP (as defined below) is less than $10.00 per share of TradeStation common stock (as adjusted for any
stock split, reverse stock split or similar adjustment following the Closing), each PIPE Investor, other than Monex, shall be entitled
to receive from TradeStation a number of additional shares of TradeStation common stock equal to the product of (x) the number of Company
PIPE Shares, excluding any Incentive Shares (as defined below) issued to such PIPE Investor at the Closing that such PIPE Investor holds
through the Measurement Date (as defined below), multiplied by (y) a fraction, (A) the numerator of which is $10.00 (as adjusted for any
stock split, reverse stock split or similar adjustment following the Closing) minus the Adjustment Period VWAP, and (B) the denominator
of which is the Adjustment Period VWAP (such additional shares, the “Additional Shares”).
If (i) at any time from the Closing through the
Measurement Date, a PIPE Investor is not the record and beneficial owner of or otherwise transfers the TradeStation common stock into
which the Company PIPE Shares are converted at the Closing, other than ordinary course of business pledges as part of prime brokerage
or other similar financing arrangements permitted under the Subscription Agreements; or (ii) at any time from the Closing through the
Measurement Date, the PIPE Investor or any person or entity acting on its behalf, at its direction or pursuant to any understanding with
the PIPE Investor directly or indirectly engages in any transaction in breach of the prohibition in the Subscription Agreements on “short
sales,” the PIPE Investor will automatically and irrevocably forfeit any right to or interest in any Additional Shares.
Monex will participate in the PIPE Investment
and has agreed to purchase 5,000,000 Company PIPE Shares pursuant to a Subscription Agreement on substantially the same terms and conditions
as the other PIPE Investors; provided that it will not be entitled to receive any Additional Shares. The Company will
issue to any PIPE Investor or group of PIPE Investors, other than Monex, whose aggregate subscription amount for Company PIPE Shares
is equal to or greater than $5 million, an additional number of Company PIPE Shares (the “Incentive Shares”)
equal to 10.0% of such aggregate subscribed-for Committed Shares for no additional consideration (which would result in the issuance
of an aggregate of 750,000 additional Incentive Shares).. The Incentive Shares are considered to be fixed and determinable and represent
a discount on the per share price at issuance. No PIPE Investor will be entitled to receive any Additional Shares in respect of the Incentive
Shares.
For purposes of the Subscription Agreements: (i)
the “Adjustment Period VWAP” means the higher of (x) the lower of (A) the average of the VWAP of a share of TradeStation common
stock, determined for each of the successive 60 trading days of the Adjustment Period (as defined below) and (B) the average of the VWAP
of a share of TradeStation common stock determined for each of the successive 10 trading days ending on and including the last day of
the Adjustment Period and (y) $6.50; (ii) the “Adjustment Period” means the 60 Trading Day period beginning on and including
the date a resale registration statement for the PIPE shares is declared effective; and (iii) the “Measurement Date” means
the last day of the Adjustment Period.
QUANTUM
FINTECH ACQUISITION CORPORATION
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
TradeStation will assume upon Closing the Company’s
obligation to file, within 15 calendar days of Closing (the “Filing Deadline”), a registration statement registering the resale
of such common stock and will use commercially reasonable efforts to have such registration statement declared effective as soon as practicable
after the filing thereof, but no later than the earlier of (i) forty-five (45) calendar days (or ninety (90) calendar days if the SEC
notifies the Company that it will “review” the registration statement) following the Filing Deadline and (ii) the third (3rd)
business day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that the registration statement
will not be “reviewed” or will not be subject to further review.
Sponsor Support Agreement
Additionally, the Company entered into a Sponsor
Support Agreement (the “Sponsor Support Agreement”) with TradeStation, Monex and the initial stockholders, pursuant to which,
among other things, each of the initial stockholders agreed to vote any of the shares of Company Common Stock held by them in favor of
the TradeStation Business Combination and not to redeem any such shares at the special meeting of stockholders to be held in connection
with the TradeStation Business Combination. In addition, the insiders agreed not to transfer (i) their TradeStation common stock following
the Closing, subject to certain exceptions, until the earlier of (A) (1) in the case of Co-Sponsors, 12 months from Closing and (2) in
the case of the Company’s directors and officers, 6 months from Closing and (B) subsequent to the Closing, the date on which the
last reported sale price of TradeStation common stock exceeds $12.50 per share for 20 out of any 30 consecutive trading days and (ii)
their TradeStation warrants following the Closing, subject to certain exceptions, until the later of (A) 30 days from Closing and (B)
February 4, 2022. In addition, pursuant to the Sponsor Support Agreement, the Co-Sponsors have agreed to forfeit at Closing for no consideration
an aggregate of 1,610,554 Founders Shares and the forfeited shares shall be deemed to be cancelled and no longer outstanding.
Vendor Agreement
On August 20, 2021, the Company entered into an
agreement with a vendor for investment banking services related to the pending Business Combination. Specifically, the agreement relates
to assisting in raising the funds as part of the PIPE financing. The agreement calls for the vendor to receive a contingent fee equal
to 3% of the aggregate purchase price of the securities sold in the private placement. If the Company engages a co-placement agent in
connection with the private placement the contingent fee will be 4% of the aggregate purchase price of the securities sold in the private
placement. In addition, the vendor will receive reimbursement of out-of-pocket expenses that shall not exceed $50,000.
NOTE 7. STOCKHOLDERS’ EQUITY
Preferred Stock - The Company
is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other
rights and preferences as may be determined from time to time by the Company’s board of directors. At December 31, 2021 and 2020,
there were no shares of preferred stock issued or outstanding.
Common stock - The Company
is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. Holders of the Company’s common
stock are entitled to one vote for each share. At December 31, 2021, there were 25,156,250 shares of common stock issued and outstanding,
including 20,125,000 shares of common stock subject to possible redemption which are presented as temporary equity. At December 31, 2020,
there were 5,031,250 shares of common stock issued and outstanding.
NOTE 8. WARRANTS
As of December 31, 2021, there are 10,062,500
Public Warrants outstanding that are classified and accounted for as equity instruments. The Public Warrants will become exercisable on
the later of (a) the completion of a Business Combination or (b) one year from the closing of the Initial Public Offering. No Public Warrants
will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock
issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing,
if a registration statement covering the shares of common stock issuable upon exercise of the Public Warrants is not effective within
120 days from the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement
and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless
basis pursuant to an available exemption from registration under the Securities Act. The Public Warrants will expire five years after
the completion of a Business Combination or earlier upon redemption or liquidation.
QUANTUM
FINTECH ACQUISITION CORPORATION
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
Once the warrants become exercisable, the Company
may redeem the Public Warrants:
| ● | in whole and not in part; |
| | |
| ● | at a price of $0.01 per warrant; |
| | |
| ● | at any time after the warrants become exercisable; |
| | |
| ● | upon not less than 30 days’ prior written notice of redemption; |
| | |
| ● | if, and only if, the reported last sale price of the shares of common stock equals or exceeds $16.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period ending on the third business day prior to the notice of redemption to warrant holders; and |
| | |
| ● | if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption. |
If the Company calls the Public Warrants for redemption,
management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,”
as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants
may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation.
However, except as described below, the warrants will not be adjusted for issuance of common stock at a price below its exercise price.
Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business
Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not
receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held
outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
In addition, if (x) the Company issues additional
common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue
price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined
in good faith by the Company’s board of directors and, in the case of any such issuance to the initial stockholders or their affiliates,
without taking into account any Founder Shares or Private Warrants held by the initial stockholders or their affiliates, as applicable,
prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than
60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation
of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its common stock during the 20 trading
day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market
Value”) is below $9.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115%
of the higher of the Market Value and Newly Issued Price, and the $16.50 per share redemption trigger price will be adjusted (to the nearest
cent) to be equal to 165% of the higher of the Market Value and the Newly Issued Price.
As of December 31, 2021, there are 6,153,125 Private
Warrants to purchase an equal number of common shares that are outstanding that are classified and accounted for as derivative liabilities.
Under this accounting treatment, the Company is required to measure the fair value of the Private Warrants at the end of each reporting
period as well as re-evaluate the treatment of the Private Warrants and recognize changes in the fair value from the prior period in the
Company’s operating results for the current period. The Private Warrants are identical to the Public Warrants underlying the Units
sold in the Initial Public Offering, except that (i) each private warrant is exercisable for one share of common stock at an exercise
price of $11.50 per share, the Private Warrants and the shares of common stock issuable upon the exercise of the Private Warrants will
not be transferable, assignable or saleable until after the completion of a Business Combination, subject to certain limited exceptions.
Additionally, the Private Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and will be non-redeemable
so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than
the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such
holders on the same basis as the Public Warrants.
QUANTUM
FINTECH ACQUISITION CORPORATION
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
NOTE
9. INCOME TAX
The Company’s net deferred tax assets (liability) at December
31, 2021 and 2020 are as follows:
| |
December 31, | | |
December 31, | |
| |
2021 | | |
2020 | |
Deferred tax assets | |
| | |
| |
Net operating loss carryforward | |
$ | 32,650 | | |
$ | 1,138 | |
Unrealized gain on marketable securities | |
| (2,743 | ) | |
| - | |
Start up costs | |
| 567,905 | | |
| - | |
Total deferred tax assets | |
| 597,812 | | |
| 1,138 | |
Valuation Allowance | |
| (597,812 | ) | |
| (1,138 | ) |
Deferred tax assets (liability), net of allowance | |
$ | - | | |
$ | - | |
The income tax (benefit) provision for the year
ended December 31, 2021 and the period from October 1, 2020 (inception) through December 31, 2020 consists of the following:
| |
December 31, | | |
December 31, | |
| |
2021 | | |
2020 | |
Federal | |
| | |
| |
Current | |
$ | - | | |
$ | - | |
Deferred | |
| (596,674 | ) | |
| (1,138 | ) |
| |
| | | |
| | |
State and Local | |
| | | |
| | |
Current | |
| - | | |
| - | |
Deferred | |
| - | | |
| - | |
| |
| | | |
| | |
Change in valuation allowance | |
| 596,674 | | |
| 1,138 | |
| |
| | | |
| | |
Income tax provision | |
$ | - | | |
$ | - | |
As of December 31, 2021 and 2020, the Company
has a total of $155,478 and $5,420, respectively, of U.S. federal net operating loss carryovers available to offset future taxable income.
The federal net operating loss can be carried forward indefinitely. As of December 31, 2021 and 2020, the Company had did not have any state net operating loss carryovers available to offset future taxable income.
In assessing the realization of the deferred tax
assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized.
The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which
temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred
tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of
the information available, management believes that significant uncertainty exists with respect to future realization of the deferred
tax assets and has therefore established a full valuation allowance. For the year ended December 31, 2021, the change in the valuation
allowance was $596,674. For the period from October 1, 2020 (inception) through December 31, 2020, the change in the valuation allowance
was $1,138.
QUANTUM
FINTECH ACQUISITION CORPORATION
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
A reconciliation of the federal income tax
rate to the Company’s effective tax rate at December 31, 2021 and 2020 is as follows, as restated:
| |
December 31, 2021 | | |
December 31, 2020 | |
| |
| | |
| |
Statutory federal income tax rate | |
| 21.0 | % | |
| 21.0 | % |
Business combination expenses | |
| (1.80 | )% | |
| (0.0 | )% |
Change in fair value of warrant liability | |
| (12.24 | )% | |
| 0.0 | % |
Change in fair value of PIPE derivative liability | |
| 3.56 | % | |
| 0.0 | % |
Transaction costs - warrants | |
| (0.03 | )% | |
| 0.0 | % |
Valuation allowance | |
| (10.48 | )% | |
| (21.00 | )% |
Income tax provision | |
| 0.0 | % | |
| 0.0 | % |
The Company files income tax returns in the
U.S. federal jurisdiction and is subject to examination by the various taxing authorities. The Company’s tax returns for the
year ended December 31, 2021 and for the period from October 1, 2020 (inception) through December 31, 2020 remain open and subject
to examination. The Company considers Florida to be a significant state tax jurisdiction.
NOTE 10. FAIR VALUE MEASUREMENTS (Restated)
Fair value is defined as the price that would
be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement
date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives
the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the
lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
|
● |
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
|
● |
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
|
● |
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
In some circumstances, the inputs used to measure
fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is
categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
At December 31, 2021, assets held in the Trust
Account were comprised of $201,308,628 in money market funds which are primarily invested in U.S. Treasury securities. During the year
ended December 31, 2021, the Company did not withdraw any interest income from the Trust Account.
The following table presents information about
the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2021, and indicates the
fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
Description | |
Level | | |
December 31, 2021 | |
Assets: | |
| | |
| |
Marketable securities held in Trust Account | |
| 1 | | |
$ | 201,308,628 | |
| |
| | | |
| | |
Liabilities: | |
| | | |
| | |
PIPE derivative liability – Additional Shares | |
| 3 | | |
$ | 4,566,000 | |
Warrant liability - Private Warrants | |
| 3 | | |
$ | 7,137,930 | |
QUANTUM
FINTECH ACQUISITION CORPORATION
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
The Private Warrants were accounted for as liabilities
in accordance with ASC 815-40 and are presented within warrant liabilities on the balance sheets. The warrant liabilities are measured
at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liability
in the statements of operations.
The Private Placement Warrants were initially
and as of the end of each subsequent report period, valued using a lattice model, specifically a binomial lattice model incorporating
the Cox-Ross-Rubenstein methodology, which is considered to be a Level 3 fair value measurement. The primary unobservable input utilized
in determining the fair value of the Private Placement Warrants is the expected volatility of the Company’s common stock. The expected
volatility of the Company’s common stock was determined based on the implied volatility of the Public Warrants.
The key inputs into the binomial lattice model
for the Private Warrants were as follows:
Input | |
February 9,
2021 (Initial Measurement)
and February 12, 2021
(over-allotment
exercise) | | |
December 31, 2021 | |
Market price of public shares | |
$ | 9.39 | | |
$ | 9.89 | |
Risk-free rate | |
| 0.54 | % | |
| 1.27 | % |
Dividend yield | |
| 0.00 | % | |
| 0.00 | % |
Volatility | |
| 14.1 | % | |
| 9.5 | % |
Exercise price | |
$ | 11.50 | | |
$ | 11.50 | |
Effective expiration date | |
| 6/20/26 | | |
| 02/25/27 | |
The PIPE Derivative was accounted for as a
liability in accordance with ASC 815-40 and are presented within current liabilities on the balance sheet as of December 31, 2021. The
PIPE derivative liability is measured at fair value at inception and on a recurring basis, with changes in fair value presented within
change in fair value of derivative liability in the statement of operations.
The Additional Shares were initially and as
of December 31, 2021, valued using a Monte Carlo model which is considered to be a Level 3 fair value measurement. The primary unobservable
input utilized in determining the fair value of the PIPE Derivative Liability is the expected volatility of the Company’s common
stock. The expected volatility of the Company’s common stock was determined based on the implied volatility of the Public Warrants.
The key inputs into the Monte Carlo model for
the PIPE Derivative Liability were as follows:
Input | |
November 4, 2021 (Initial Measurement) | | |
December 31, 2021 | |
Market price of Public Shares as of measurement date | |
$ | 9.96 | | |
$ | 9.89 | |
Risk-free rate | |
| 0.14 | % | |
| 0.33 | % |
Dividend yield | |
| 0.00 | % | |
| 0.00 | % |
Volatility | |
| 17.0 | % | |
| 14.5 | % |
Term (in years) | |
| 0.99 | | |
| 0.84 | |
The following table presents the changes in
the fair value of the PIPE Derivative Liability and the warrant liability:
| |
Private Placement | | |
PIPE Derivative Liability | |
Fair value as of January 1, 2021 | |
$ | — | | |
$ | — | |
Initial measurement on February 9, 2021 | |
| 3,448,750 | | |
| — | |
Exercising of underwriters’ over-allotment on February 12, 2021 | |
| 366,188 | | |
| — | |
Initial measurement on November 4, 2021 | |
| — | | |
| 5,532,000 | |
Change in valuation inputs or other assumptions | |
| 3,322,992 | | |
| (966,000 | ) |
Fair value as of December 31, 2021 | |
$ | 7,137,930 | | |
$ | 4,566,000 | |
There were no transfers between levels during
the year ended December 31, 2021.
QUANTUM
FINTECH ACQUISITION CORPORATION
NOTES
TO FINANCIAL STATEMENTS
DECEMBER 31, 2021 (Restated) AND 2020
NOTE 11. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
The Company concluded it should restate its previously
issued financial statements by amending its Annual Report on Form 10-K, filed with the SEC on March 9, 2022, to classify the Additional
Shares (as discussed in Note 6), pursuant to the Subscription Agreement entered into on November 4, 2021, as a derivative liability in
accordance with ASC 815-40. Previously, the Company did not consider the Additional Shares as a derivative liability.
The Additional Shares include settlement provisions
that could change the settlement amounts depending on the characteristics of the instrument holder. Because the holder of an instrument
is not an input to a fixed-for-fixed option pricing model, this instrument is not considered indexed to the entity’s own stock under
step 2 of the indexation guidance and, therefore, should be classified as a liability.
As a result of the above, the Company should have
classified the Additional Shares as a derivative liability in its previously issued financial statements. Under this accounting treatment,
the Company is required to measure the fair value of the PIPE derivative liability at the time the Company entered into the Subscription
Agreement and at the end of each reporting period and recognize change in fair value in the Company’s operating results for the
current period.
In addition, this restatement includes additional
information pertaining to (i) the Amendment to the Merger Agreement dated December 17, 2021, which impacted, among other things, the
formula to convert common stock held by our public stockholders upon consummation of the proposed business combination, (ii) the Additional
Shares described in the Subscription Agreement, (iii) the Incentive Shares described in the Subscription Agreement, (iv) re-assessment
of the Company’s ability to continue as a going concern due to the impact of the Merger Agreement and the Company’s ability
to access their sponsor commitment to alleviate the working capital deficit (See Note 5), and (v) the Company entered into an unsecured
promissory note evidencing Working Capital Loans on March 14, 2022, effective as of January 3, 2022, in the amount of up to $480,000
with Quantum Ventures.
The impact of the restatement is presented below:
Balance Sheet as of December 31, 2021 | |
As Previously Reported | | |
Adjustment | | |
As Restated | |
PIPE derivative liability | |
$ | — | | |
$ | 4,566,000 | | |
$ | 4,566,000 | |
Total Current Liabilities | |
$ | 2,642,531 | | |
$ | 4,566,000 | | |
$ | 7,208,531 | |
Total Liabilities | |
$ | 9,780,461 | | |
$ | 4,566,000 | | |
$ | 14,346,461 | |
Accumulated deficit | |
$ | (9,319,707 | ) | |
$ | (4,566,000 | ) | |
$ | (13,885,707 | ) |
Total Stockholders’ Deficit | |
$ | (9,319,204 | ) | |
$ | (4,566,000 | ) | |
$ | (13,885,204 | ) |
Statement of Operations for the Year Ended December 31, 2021 | |
As Previously Reported | | |
Adjustment | | |
As Restated | |
Change in fair value of PIPE derivative liability | |
$ | — | | |
$ | 966,000 | | |
$ | 966,000 | |
Total other expenses, net | |
$ | (3,264,364 | ) | |
$ | 966,000 | | |
$ | (2,298,364 | ) |
Net loss | |
$ | (6,668,793 | ) | |
$ | 966,000 | | |
$ | (5,702,793 | ) |
Basic and diluted net loss per share, Redeemable common stock | |
$ | (0.29 | ) | |
$ | 0.04 | | |
$ | (0.25 | ) |
Basic and diluted net loss per share, Non-redeemable common
stock | |
$ | (0.29 | ) | |
$ | 0.04 | | |
$ | (0.25 | ) |
Statement of Changes in Stockholders’ Equity (Deficit) for
the Year Ended December 31, 2021 | |
As Previously Reported | | |
Adjustment | | |
As Restated | |
Fair value of PIPE derivative liability at issuance | |
$ | — | | |
$ | (5,532,000 | ) | |
$ | (5,532,000 | ) |
Net loss | |
$ | (6,668,793 | ) | |
$ | 966,000 | | |
$ | (5,702,793 | ) |
Total Stockholders’ Deficit | |
$ | (9,319,204 | ) | |
$ | (4,566,000 | ) | |
$ | (13,885,204 | ) |
Statement of
Cash Flows for the Year Ended December
31, 2021 | |
As Previously Reported | | |
Adjustment | | |
As Restated | |
Non-Cash investing and financing activities: | |
| | |
| | |
| |
Initial classification of PIPE derivative liability | |
$ | — | | |
$ | 5,532,000 | | |
$ | 5,532,000 | |
NOTE 12. SUBSEQUENT EVENTS (Restated)
The Company evaluated subsequent events and
transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this
review, other than noted below, the Company did not identify any subsequent events that would have required adjustment or disclosure
in the financial statements.
In February 2022, Quantum Ventures committed to provide the Company
an additional $1,000,000 for a total of $3,000,000 in loans in connection with the Working Capital Loans as described in Note 5. The Company
needs approval from TradeStation to borrow amounts over $500,000.
On March 14, 2022, the Company issued an unsecured promissory note,
effective as of January 3, 2022, in the amount of up to $480,000 to Quantum Ventures to evidence the Working Capital Loans. The note bears
no interest and is payable in full upon the earlier (i) February 9, 2023 and (ii) the effective date of the consummation of our initial
business combination. The note is required to be repaid in cash at the Closing and is not convertible into private warrants. As of the
date of this filing, a principal balance of $242,101 has been advanced.